Document:

Exhibit 10.1

 

EXECUTION VERSION

 

		Date:	November 10, 2021

 

		To:	Wejo Limited (“Counterparty”)

 

		Address:	ABC Building, 21-23 Quay Street, Manchester M3 4AE, England

 

		From:	Each entity specified as a “Seller” on Annex I hereto, severally and not jointly (each the “Seller”)

 

		Re:	OTC Equity Prepaid Forward Transaction

 

The purpose of this agreement (this “Confirmation”)
is to confirm the terms and conditions of the transaction (the “Transaction”) entered into between Seller and Counterparty
on the Trade Date specified below. Certain terms of the Transaction shall be as set forth in this Confirmation, with additional terms
as set forth in a Pricing Date Notice (the “Pricing Date Notice”) in the form of Schedule A hereto. This Confirmation,
together with the Pricing Date Notice, constitutes a “Confirmation” and the Transaction constitutes a separate “Transaction”
as referred to in the ISDA Form (as defined below).

 

This Confirmation, together with the Pricing Date Notice, evidences
a complete binding agreement between Seller and Counterparty as to the subject matter and terms of the Transaction to which this Confirmation
relates and shall supersede all prior or contemporaneous written or oral communications with respect thereto.

 

The 2006 ISDA Definitions (the “Swap Definitions”)
and the 2002 ISDA Equity Derivatives Definitions (the “Equity Definitions”, and with the Swap Definitions, the “Definitions”),
each as published by the International Swaps and Derivatives Association, Inc., are incorporated into this Confirmation. If there is any
inconsistency between the Definitions and this Confirmation, this Confirmation governs. If, in relation to the Transaction to which this
Confirmation relates, there is any inconsistency between the ISDA Form, this Confirmation (including the Pricing Date Notice), the Swap
Definitions and the Equity Definitions, the following will prevail for purposes of such Transaction in the order of precedence indicated:
(i) this Confirmation (including the Pricing Date Notice); (ii) the Equity Definitions; (iii) the Swap Definitions, and (iv) the ISDA
Form.

 

This Confirmation, together with the Pricing Date Notice, shall supplement,
form a part of, and be subject to an agreement in the form of the 2002 ISDA Master Agreement (the “ISDA Form”) as if
Seller and Counterparty had executed an agreement in such form (but without any Schedule except as set forth herein under “Schedule
Provisions”) on the Trade Date of the Transaction.

 

It is understood and agreed that this document shall constitute a separate
agreement with each party specified on Annex I attached hereto, as if each such party had executed a separate document naming only itself
as Seller, and that no party specified on the Annex I shall have any liability under this document for the obligations of any other party
so specified. For the avoidance of doubt, no Event of Default, Potential Event of Default or Termination Event under one Confirmation
by any one Seller specified on Annex I will constitute an Event of Default, Potential Event of Default or Termination Event with respect
to any other Seller specified on Annex I. With respect to any one such party, any references in this Confirmations to the ISDA Form shall
be deemed to refer to the ISDA Form as prepared for such party. Counterparty acknowledges and agrees that the separation of assets, liabilities,
and obligations of each separate Seller shall not be challenged, notwithstanding the fact that such agreements are included in a single
document.

 

The terms of the particular Transaction to which this Confirmation
relates are as follows:

 

	
    General Terms
	 	 
	 	 	 
	Type of Transaction:	 	Share Forward Transaction
	 	 	 
	Trade Date:	 	November 10, 2021
	 	 	 
	Pricing Date:	 	As specified in the Pricing Date Notice.
	 	 	 
	Effective Date:	 	One (1) Settlement Cycle following the Pricing Date
	 	 	 
	Valuation Date:	 	The second anniversary of the closing of Business Combination (as defined below) pursuant to the Agreement and Plan of Merger, dated as of May 28, 2021, between Wejo Group Limited (the “Company”), Yellowstone Merger Sub, Inc. (“Merger Sub”), Wejo Bermuda Limited, Counterparty and Issuer whereby Merger Sub will merge with and into Issuer, with Issuer being the surviving corporation in the merger and a direct, wholly-owned subsidiary of the Company, as reported on the Form 8-K filed by the Issuer on May 28, 2021 (the “Form 8-K”) (the “Business Combination”).
	 	 	 
	Pricing Date Notice:	 	Seller shall deliver to Counterparty a Pricing Date Notice as soon as practicable after, and on the same day as, the closing of the Business Combination occurs.
	 	 	 
	Seller:	 	Seller

 

     

     

    

 

	Buyer:	 	Counterparty 
	 	 	 
	Shares:	 	The Class A common stock of Issuer prior to the closing of the Business Combination; common shares of Company following the closing of the Business Combination
	 	 	 
	Issuer:	 	Virtuoso Acquisition Corp., a Delaware corporation (Ticker: “VOSOU”) prior to the closing of the Business Combination; Company following the closing of the Business Combination
	 	 	 
	Number of Shares:	 	“Total Purchased Shares Amount” as specified in the Pricing Date Notice (the “Total Purchased Shares Amount”), but in no event more than the Maximum Number of Shares. The Total Purchased Shares Amount is subject to reduction as described under “Optional Early Termination” and “Early Partial Settlement” provisions below.
	 	 	 
	Maximum Number of Shares:	 	7,500,000; provided that to the extent that two or more Sellers deliver a Pricing Date Notice to Counterparty, the aggregate of the Total Purchased Shares Amounts across all such Pricing Date Notices must not exceed 7,500,000. 
	 	 	 
	Forward Price:	 	The Redemption Price (the “Redemption Price”) as defined in Section 9.2 of the Amended and Restated Certificate of Incorporation of Issuer filed with the Secretary of State of the State of Delaware on January 21, 2021, as amended from time to time (the “Certificate of Incorporation”).
	 	 	 
	Prepayment:	 	Applicable 
	 	 	 
	Prepayment Amount:	 	
    An amount equal to 100% of the Forward Price multiplied by the Total
    Purchased Shares Amount.

     

    Counterparty will pay to Seller the Prepayment Amount at market open
    on the Prepayment Date.

	 	 	 
	Prepayment Date:	 	One (1) Local Business Day after the closing of the Business Combination 
	 	 	 
	Variable Obligation:	 	Not applicable 
	 	 	 
	Exchange(s):	 	Nasdaq Stock Market
	 	 	 
	Related Exchange(s):	 	All Exchanges
	 	 	 
	Reimbursement of Legal Fees:	 	
    On the Trade Date, Counterparty shall pay to all Sellers an amount
    (the “Trade Date Fee Amount”) equal to the lesser of (a) the attorney fees and other reasonable expenses related thereto
    incurred by the Sellers or their affiliates in connection with the Transactions entered into by the Sellers, on a several and not joint
    basis (the “Legal Fees”) and (b) $100,000 (the “Fee Cap Amount”).

     

    If the Trade Date Fee Amount is less than the Fee Cap Amount, on the
    Effective Date, Counterparty shall pay to all Sellers an amount equal to the lesser of (a) the Legal Fees incurred by the Sellers but
    not reimbursed under the Trade Date Fee Amount and (b) Fee Cap Amount minus the Trade Date Fee Amount.

     

    For the avoidance of doubt, notwithstanding the several and not joint
    nature of each Seller’s obligations hereunder, the “Reimbursement of Legal Fees” provisions will be calculated on an
    aggregate basis across all Sellers.

	 	 	 
	Settlement Terms	 	 
	 	 	 
	Settlement Method Election:	 	Not Applicable 
	 	 	 
	Settlement Method:	 	Physical Settlement; provided that Section 9.2 of the Equity Definitions shall be amended by adding “or its designee” after “Buyer” in Section 9.2(a)(iii) and in the last paragraph thereof. 
	 	 	 
	Settlement Currency:	 	USD
	 	 	 
	Excess Dividend Amount	 	Ex Amount 

 

    Page 2

     

    

 

	Optional Early Termination:	 	
    From time to time and on any Exchange Business Day following the date
    of closing of the Business Combination, Seller may, in its absolute discretion, terminate the Transaction in whole or in part by giving
    written notice to Counterparty (the “OET Notice”).

     

    Seller will deliver the OET Notice within one (1) Business Day of a
    sale by Seller of any Shares after the date of closing of the Business Combination (excluding any sales pursuant to the “Early Partial
    Settlement” provisions below).

     

    The OET Notice will specify the number of shares sold by Seller (the
    “Terminated Shares”) and the settlement date of the sale for such Terminated Shares (the “OET Settlement Date”).
    On each OET Settlement Date, (i) Seller shall pay to Counterparty an amount equal to the product of (x) the number of Terminated Shares
    and (y) the Forward Price; and (ii) the Total Purchased Shares Amount will be reduced by the number of Terminated Shares.

     

    The remainder of the Transaction, if any, shall continue in accordance
    with its terms; provided that if the OET Settlement Date is also the stated Valuation Date, the remainder of the Transaction shall be
    settled in accordance with the other provisions of “Settlement Terms.”

	 	 	 
	Early Partial Settlement:	 	
    If a Share Excess Event occurs, Counterparty may deliver a written
    notice to Seller requesting early partial settlement of the Transaction (the “Early Settlement Notice”); provided that,
    (i) in the case of the 6-month Excess Event, the Early Settlement Notice may be delivered on any Exchange Business Day during the continuation
    of such Share Excess Event, and (ii) in the case of 1-year Excess Event, the Early Settlement Notice must be delivered within five (5)
    Local Business Days after such Share Excess Event occurs (unless such Share Excess Event occurs during a Blackout Period, then the Early
    Settlement Notice must be delivered within five (5) Local Business Days after the end of the Blackout Period).

     

    As soon as practicable after receipt by Seller of an Early Settlement
    Notice, Seller will sell the Excess Shares, acting in its absolute discretion as to the manner and process of such sale, and on the Early
    Settlement Date pay to Counterparty an amount (the “Early Settlement Amount”) equal to the lesser of (a) the number
    of Excess Shares sold multiplied by the Forward Price and (b) the net sale proceeds received by Seller for such Excess Shares sold; provided
    that, if the Excess Shares are trading below the Forward Price, Counterparty may request, in the Early Settlement Notice, Seller to transfer
    the Excess Shares to the designee of Counterparty (the “Transfer”) instead of selling such shares in the market (such
    Excess Shares sold or transferred, the “Early Settled Shares”).

     

    Seller shall effect the Transfer as soon as practicable after receipt
    by Seller of an Early Settlement Notice; provided that if on the date of, but prior to, the Transfer the trading price of Excess Shares
    is above the Forward Price, Seller shall not be obligated to effect the Transfer and may instead elect to sell the Excess Shares in accordance
    with the preceding paragraph as though the request for Transfer was not included in the Early Settlement Notice.

     

    Seller’s obligations under this Transaction with respect to the
    Early Settled Shares shall be completely discharged upon the Transfer of the Excess Shares or the payment of the Early Settlement Amount,
    as applicable.

     

    On each Early Settlement Date, the Total Purchased Shares Amount will
    be reduced by the Excess Shares sold or transferred on such date.

     

    “Blackout Period” means the “Blackout Period”
    as defined in accordance with the Company’s insider trading policy.

     

    “Early Settlement Date” means the date that Seller
    (a) in the case of a sale of Excess Shares, receives the net sale proceeds with respect to such Excess Shares or (ii) in the case of a
    Transfer of Excess Shares, effects the Transfer of such Excess Shares.

     

    “Excess Shares” means (a) the amount of Shares
held by Seller at the time of the Share Excess Event, minus (b)(i) in the case of the 6-month Excess Event, 75% of the Total Purchased
Shares Amount of Shares, or (ii) in the case of the 1-year Excess Event, 50% of the Total Purchased Shares Amount of Shares. 

    

 

    Page 3

     

    

 

	 	 	“Share Excess Event” will occur if: (i) after
the 6-month anniversary of closing of Business Combination, less than 25% of the Total Purchased Shares Amount of Shares (as specified
in the Pricing Date Notice) have become Terminated Shares (the “6-month Excess Event”); or (ii) on the 1-year anniversary
of closing of Business Combination, less than 50% of the Total Purchased Shares Amount of Shares (as specified in the Pricing Date Notice)
have become Terminated Shares or Early Settled Shares (the “1-year Excess Event”) (in each case of (i) and (ii), determined
as of 5 p.m. New York time on (x) with respect to the 6-month Excess Event, each Exchange Business Day, and (y) with respect to the 1-year
Excess Event, on such 1-year anniversary (or if such date is not an Exchange Business Day, on the next Exchange Business Day). 
	 	 	 
	Share Adjustments:	 	 
	 	 	 
	Method of Adjustment:	 	Calculation Agent Adjustment
	 	 	 
	Extraordinary Events:	 	 
	 	 	 
	Consequences of Merger Events:	 	 
	 	 	 
	Share-for-Share:	 	Calculation Agent Adjustment 
	 	 	 
	Share-for-Other:	 	Cancellation and Payment 
	 	 	 
	Share-for-Combined:	 	Component Adjustment 
	 	 	 
	Tender Offer:	 	Applicable; provided, however, that Section 12.1(d) of the Equity Definitions is hereby amended by adding “, or of the outstanding Shares,” before “of the Issuer” in the fourth line thereof. Sections 12.1(e) and 12.1(l)(ii) of the Equity Definitions are hereby amended by adding “or Shares, as applicable,” after “voting shares”.
	 	 	 
	Consequences of Tender Offers:	 	 
	 	 	 
	Share-for-Share:	 	Calculation Agent Adjustment 
	 	 	 
	Share-for-Other:	 	Calculation Agent Adjustment 
	 	 	 
	Share-for-Combined:	 	Calculation Agent Adjustment 
	 	 	 
	Composition of Combined Consideration:	 	Not Applicable 
	 	 	 
	Nationalization, Insolvency or Delisting:	 	
    Cancellation and Payment (Calculation Agent Determination); provided
    that the definition of “Delisting” is hereby deleted in its entirety and replaced with the following:

     

    “Delisting” means that the Exchange announces that the
    Shares cease (or will cease) to be listed, traded or publicly quoted on the Exchange for any reason (and are not immediately re-listed,
    re-traded or re-quoted on any of the New York Stock Exchange, the Nasdaq Stock Market (including Nasdaq Global Select Market, the Nasdaq
    Capital Market or the Nasdaq Global Market) (or their respective successors) or such other exchange or quotation system which, in the
    determination of the Calculation Agent, has liquidity comparable to the aforementioned exchanges; if the Shares are immediately re-listed,
    re-traded or re-quoted on any such exchange or quotation system, such exchange or quotation system shall be deemed to be the Exchange.

     

    Notwithstanding anything to the contrary in the Definitions or the
    ISDA Form, if Delisting occurs prior to closing of the Business Combination, Counterparty will pay to Seller on the day of such Delisting
    the “Cancellation Amount” equal to 100% of the Forward Price multiplied by the number of Shares held by Seller as of such
    date (the “Total Delisted Shares”) and, upon the receipt of such Cancellation Amount, the Seller will, at its option,
    either transfer the Total Delisted Shares to Counterparty (or its designee) or sell the Total Delisted Shares in the market and pay to
    Counterparty an amount equal to the Forward Price multiplied by the number of Delisted Shares sold. Seller’s obligations under this
    Transaction with respect to the Delisted Shares shall be completely discharged upon such transfer or payment, as applicable.

	 	 	 
	Business Combination Exclusion:	 	Notwithstanding the foregoing or any other provision herein, the parties agree that the Business Combination shall not constitute a Merger Event, Tender Offer, Delisting or any other Extraordinary Event hereunder.

 

    Page 4

     

    

 

	Additional Disruption Events:	 	 
	 	 	 
	(a)  Change in Law:	 	Applicable; provided that Section 12.9(a)(ii) of the Equity Definitions is hereby amended by adding the words “(including, for the avoidance of doubt and without limitation, adoption or promulgation of new regulations authorized or mandated by existing statute)” after the word “regulation” in the second line thereof.
	 	 	 
	(a)  Failure to Deliver:	 	Not Applicable
	 	 	 
	(b)  Insolvency Filing:	 	Applicable
	 	 	 
	(c)  Hedging Disruption:	 	Not Applicable
	 	 	 
	(d)  Increased Cost of Hedging:	 	Not Applicable
	 	 	 
	(e)  Loss of Stock Borrow:	 	Not Applicable
	 	 	 
	(f)  Increased Cost of Stock Borrow:	 	Not Applicable
	 	 	 
	Determining Party:	 	For all applicable events, Seller, unless (i) an Event of Default, Potential Event of Default or Termination Event has occurred and is continuing with respect to Seller, or (ii) if Seller fails to perform its obligations as Determining Party, in which case a Third Party Dealer (as defined below) in the relevant market selected by Counterparty will be the Determining Party.
	 	 	 
	Additional Provisions:	 	 
	 	 	 
	Calculation Agent:	 	
    Seller, unless (i) an Event of Default, Potential Event of Default
or Termination Event has occurred and is continuing with respect to Seller, or (ii) if Seller fails to perform its obligations as Calculation
Agent, in which case an unaffiliated leading dealer in the relevant market selected by Counterparty will be the Calculation Agent. 

	 	 	 
	Non-Reliance:	 	Applicable
	 	 	 
	Agreements and Acknowledgements Regarding Hedging Activities:	 	Applicable
	 	 	 
	Additional Acknowledgements:	 	Applicable
	 	 	 
	Schedule Provisions:	 	 
	 	 	 
	Specified Entity:	 	
    In relation to both Seller and Counterparty for the purpose of:

     

    Section 5(a)(v), Not Applicable

    Section 5(a)(vi), Not Applicable

    Section 5(a)(vii), Not Applicable

    Section 5(b)(v), Not Applicable

	 	 	 
	Cross-Default	 	The “Cross-Default” provisions of Section 5(a)(vi) of the ISDA Form will not apply to either party.
	 	 	 
	Credit Event Upon Merger	 	The “Credit Event Upon Merger” provisions of Section 5(b)(v) of the ISDA Form will not apply to either party.
	 	 	 
	Automatic Early Termination:	 	The “Automatic Early Termination” of Section 6(a) of the ISDA Form will not apply to either party. 
	 	 	 
	Termination Currency:	 	United States Dollars 
	 	 	 
	Additional Termination Event:	 	
    Will apply to Seller and will apply to Counterparty. The occurrence
    of the following event shall constitute an Additional Termination Event in respect of which Seller and Counterparty shall both be Affected
    Parties:

     

    The Business Combination fails to close on or before December
31, 2021. 

    

 

    Page 5

     

    

 

	 	 	If this Transaction terminates due to the occurrence of the foregoing
    Additional Termination Event, then, subject to the immediately following sentence, no further payments or deliveries shall be due by either
    Seller to Counterparty or Counterparty to Seller in respect of the Transaction, including without limitation in respect of any settlement
    amount, breakage costs or any amounts representing the future value of the Transaction, and neither party shall have any further obligation
    under the Transaction and, for the avoidance of doubt and without limitation, no payments will have accrued or be due under Sections 2,
    6 or 11 of the ISDA Form. Notwithstanding the foregoing, Counterparty’s obligations set forth under the captions, “‘Reimbursement
    of Legal Fees,” and “Other Provisions — (d) Indemnification” shall survive any termination due to the occurrence
    of the foregoing Additional Termination Event.
	 	 	 
	Additional Event of Default:	 	
    Notwithstanding anything to the contrary in the ISDA Form, failure
    by Counterparty to pay the Prepayment Amount on the Prepayment Date shall be an additional Event of Default with respect to Counterparty
    as the Defaulting Party (the “Prepayment Amount Event of Default”) and shall not constitute an Event of Default under
    Section 5(a)(i) of the ISDA Form.

     

    If the Prepayment Amount Event of Default occurs, on the third (3rd)
    Business Day after the Prepayment Date and on each weekly anniversary thereafter until the Prepayment Amount plus all amounts due under
    Section 9(h)(i)(1) of the ISDA Form are paid to Seller in full, the Prepayment Amount will increase by $5,000,000 up to a cap of $150,000,000.
    For the avoidance of doubt, the calculation of the Early Termination Amount under the ISDA Form will take into account the increase in
    the Prepayment Amount payable pursuant to this paragraph.

     

    With respect to the Prepayment Amount Event of Default only, “Default
    Rate” in the ISDA Form means a rate per annum equal to the cost (without proof or evidence of any actual cost) to the relevant
    payee (as certified by it) if it were to fund or of funding the relevant amount plus 2% per annum.

     

    Notwithstanding the several and not joint nature of each Seller’s
obligations hereunder, the $5,000,000 increases and $150,000,000 cap set forth above will be calculated on an aggregate basis across
all Sellers, pro rata to their respective share of the Number of Shares. 

	 	 	 
	Governing Law:	 	New York law (without reference to choice of law doctrine)
	 	 	 
	Credit Support Document:	 	With respect to Seller and Counterparty, None.
	 	 	 
	Credit Support Provider:	 	With respect to Seller and Counterparty, None.
	 	 	 
	Local Business Days:	 	
    Seller specifies the following places for the purposes of the definition
    of Local Business Day as it applies to it: New York.

     

    Counterparty specifies the following places for the purposes of the
    definition of Local Business Day as it applies to it: New York.

 

Representations, Warranties and Covenants

 

Each of Counterparty and Seller represents and warrants to, and covenants
and agrees with, the other as of the date on which it enters into the Transaction that (in the absence of any written agreement between
the parties that expressly imposes affirmative obligations to the contrary for the Transaction):

 

		(a)	Non-Reliance. It is acting for its own account, and it has made its own independent decisions to enter into the Transaction
and as to whether the Transaction is appropriate or proper for it based upon its own judgment and upon advice from such advisers as it
has deemed necessary. It is not relying on any communication (written or oral) of the other party as investment advice or as a recommendation
to enter into the Transaction, it being understood that information and explanations related to the terms and conditions of the Transaction
will not be considered investment advice or a recommendation to enter into the Transaction. No communication (written or oral) received
from the other party will be deemed to be an assurance or guarantee as to the expected results of the Transaction.

 

		(b)	Assessment and Understanding. It is capable of assessing the merits of and understanding (on its own behalf or through
independent professional advice), and understands and accepts, the terms, conditions and risks of the Transaction. It is also capable
of assuming, and assumes, the risks of the Transaction.

 

		(c)	Non-Public Information. It is in compliance with Section 10(b) under the Securities Exchange Act of 1934, as amended
(the “Exchange Act”).

 

    Page 6

     

    

 

		(d)	Eligible Contract Participant. It is an “eligible contract participant” under, and as defined in, the Commodity
Exchange Act (7 U.S.C. § 1a(18)) and CFTC regulations (17 CFR § 1.3).

 

		(e)	Private Placement. It (i) is an “accredited investor” as such term is defined in Regulation D as promulgated
under the Securities Act of 1933, as amended (the “Securities Act”), (ii) is entering into the Transaction for its
own account without a view to the distribution or resale thereof and (iii) understands that the assignment, transfer or other disposition
of the Transaction has not been and will not be registered under the Securities Act.

 

		(f)	Investment Company Act. It is not and, after giving effect to the Transaction, will not be required to register as an
“investment company” under, and as such term is defined in, the Investment Company Act of 1940, as amended.

 

		(g)	Authorization. The Transaction has been entered into pursuant to authority granted by its board of directors or other
governing authority. It has no internal policy, whether written or oral, that would prohibit it from entering into any aspect of the Transaction.

 

Counterparty represents and warrants to, and covenants and agrees with
Seller as of the date on which it enters into the Transaction that (in the absence of any written agreement between the parties that expressly
imposes affirmative obligations to the contrary for the Transaction):

 

		(a)	Total Assets. It has total assets of at least $37,642,000 as of the date hereof.

 

		(b)	Non-Reliance. Without limiting the generality of Section 13.1 of the Equity Definitions, Counterparty acknowledges that
Seller is not making any representations or warranties or taking any position or expressing any view with respect to the treatment of
the Transaction under any accounting standards.

 

		(c)	Solvency. Counterparty is, and shall be as of the date of any payment or delivery by Counterparty under the Transaction,
solvent and able to pay its debts as they come due, with assets having a fair value greater than liabilities and with capital sufficient
to carry on the businesses in which it engages. Counterparty: (i) has not engaged in and will not engage in any business or transaction
after which the property remaining with it will be unreasonably small in relation to its business, (ii) has not incurred and does not
intend to incur debts beyond its ability to pay as they mature, and (iii) as a result of entering into and performing its obligations
under the Transaction, (a) it has not violated and will not violate any relevant state law provision applicable to the acquisition or
redemption by an issuer of its own securities and (b) it would not be nor would it be rendered “insolvent” (as such term is
defined under Section 101(32) of the Bankruptcy Code).

 

		(d)	Public Reports. Counterparty is and will remain in compliance with its reporting obligations under the Securities Act
and the Exchange Act, and all reports and other documents filed (or to be filed) by Counterparty with the Securities and Exchange Commission
pursuant to the Securities Act and the Exchange Act, when considered as a whole (with the most recent such reports and documents deemed
to amend inconsistent statements contained in any earlier such reports and documents), do not contain any untrue statement of a material
fact or any omission of a material fact required to be stated therein or necessary to make the statements therein, in the light of the
circumstances under which they were made, not misleading.

 

		(e)	No Distribution. Counterparty is not entering into the Transaction to facilitate a distribution of the Shares (or any
security that may be converted into or exercised or exchanged for Shares, or whose value under its terms may in whole or in significant
part be determined by the value of the Shares) or in connection with any future issuance of securities.

 

		(f)	Form 8-K. Counterparty will not file, and cause the Issuer to not file, with the Securities and Exchange Commission
any Form 8-K that includes any disclosure regarding this Confirmation or the Transaction without consulting with and reasonably considering
any comments received from Seller.

 

		(g)	No Affiliation. Counterparty, to the best of its knowledge, and each other person that is directly or indirectly through
one or more intermediates controlling or controlled by or under common control with Counterparty is not to be considered and shall not
become or be considered an “affiliate” (as defined in Rule 144 under the Securities Act) of Seller at any time during the
term of the Transaction.

 

    Page 7

     

    

 

		(h)	No Violation or Conflict. The execution, delivery and performance by Counterparty of this Confirmation and the Transaction
hereunder (including any payment required hereunder) do not (and will not) (x) violate or conflict with (i) any law, statute, rule or
regulation applicable to Wejo Group, (ii) any provision of Wejo Group’s constitutional documents (including any articles of incorporation,
operating agreements or by-laws), (iii) any order or judgment of any court or agency of government applicable to Wejo Group or any of
Wejo Group’s assets, or (iv) any provision of any indenture, certificate of designation for preferred stock, agreement or other
instrument to which the Wejo Group is a party or by which it or its property may be bound, or (y) result in a breach of or constitute
(alone or with due notice or lapse of time or both) a default under, give rise to a right of or result in any cancellation or acceleration
of any right or obligation (including any payment) under any such indenture, certificate of designation for preferred stock, agreement
or other instrument.

 

“Wejo Group” means
Counterparty, the Company and any of their subsidiaries.

 

		(i)	Compliance with Laws. None of Wejo Group and its properties or assets is in violation of (nor will the continued operation
of their material properties and assets as currently conducted violate) any law, rule or regulation (including any zoning, building, ordinance,
code or approval or any building permit) or is in default with respect to any judgment, writ, injunction or decree of any governmental
authority.

 

		(j)	No Filings. Other than the filing of the Form 8-K referred to in paragraph (f) above, neither the Counterparty nor the
Issuer have to make any regulatory or governmental filings or receive any regulatory or governmental approvals related to the Transaction.

 

Seller represents and warrants to, and covenants and agrees with Counterparty
as of the date on which it enters into the Transaction and each other date specified that (in the absence of any written agreement between
the parties that expressly imposes affirmative obligations to the contrary for the Transaction):

 

		(a)	Regulatory Filings. Seller is in compliance with all material regulatory filings relating to the Issuer and the Transaction.

 

		(b)	No Affiliation. Seller and each other person that is directly or indirectly through one or more intermediates controlling
or controlled by or under common control with the Seller is not to be considered and shall not become or be considered an “affiliate”
(as defined in Rule 144 under the Securities Act) of the Counterparty at any time during the term of the Transaction.

 

Transactions by Seller in the Shares

 

		(a)	Seller hereby waives the redemption rights (“Redemption Rights”) set forth in Section 9.2 of the Certificate of
Incorporation in connection with the Business Combination with respect to Shares it acquires from holders of Shares other than the Issuer
or affiliates of the Issuer (each, a “Third Party Shareholder”) who have redeemed Shares or indicated an interest in
redeeming Shares pursuant to the Redemption Rights during the period (the “Hedging Period”) beginning on the date of
execution of this Confirmation and ending at the earlier of (x) the time reversals of redemptions in connection with the Business Combination
are no longer permitted, (y) the date that a Delisting occurs, or (z) the date that a Potential Event of Default, Event of Default or
a Termination Event occurs with respect to Counterparty as the Defaulting Party or the Affected Party (the Shares so acquired, the “Subject
Shares”). For the avoidance of doubt, Seller may sell or otherwise transfer or dispose of any of the Subject Shares or any other
shares or securities of the Issuer in one or more public or private transactions at any time; provided that, if such sales of Subject
Shares are to be settled during the Hedging Period, such transferee also agrees to waive Redemption Rights with respect to such Subject
Shares; and provided further, that upon the settlement of any sale of Subject Shares after closing of Business Combination, “Optional
Early Termination” provisions above shall apply. Any Subject Shares sold by Seller during the term of the Transaction will cease
to be Subject Shares.

 

		(b)	Seller will give written notice to Counterparty of any sale of Subject Shares by Seller that settles during the Hedging Period within
one (1) Local Business Day following the date of such sale, such notice to include the date of the sale and the number of Subject Shares
sold.

 

No Arrangements

 

Seller and Counterparty each acknowledge and agree that: (i) there
are no voting, hedging or settlement arrangements between Seller and Counterparty with respect to any Shares or the Issuer, other than
those set forth herein; (ii) although Seller may hedge its risk under the Transaction in any way Seller determines, Seller has no obligation
to hedge with the purchase or maintenance of any Shares or otherwise; (iii) Counterparty will not be entitled to any voting rights in
respect of any of the Shares underlying the Transaction unless and until it acquires such Shares; and (iv) Counterparty will not seek
to influence Seller with respect to the voting of any Hedge Positions of Seller consisting of Shares unless and until it acquires such
Shares.

 

    Page 8

     

    

 

Wall Street Transparency and Accountability Act

 

In connection with Section 739 of the Wall Street Transparency and
Accountability Act of 2010 (“WSTAA”), the parties hereby agree that neither the enactment of WSTAA or any regulation
under WSTAA, nor any requirement under WSTAA or an amendment made by WSTAA, nor any similar legal certainty provision in any legislation
enacted, or rule or regulation promulgated, on or after the date of this Confirmation, shall limit or otherwise impair either party’s
otherwise applicable rights to terminate, renegotiate, modify, amend or supplement this Confirmation or the ISDA Form, as applicable,
arising from a termination event, force majeure, illegality, increased costs, regulatory change or similar event under this Confirmation,
the Equity Definitions incorporated herein, or the ISDA Form.

 

Address for Notices

 

Notice to Seller:

 

c/o the Investment Manager listed in Annex I

9 West 57th Street, New York NY 10019

Attention: Joseph D. Glatt

Telephone No.: 212-822-0456

Email: jglatt@apollo.com

 

With a mandatory copy to:

Attention: Ryan Simes

Email: rsimes@apollo.com

 

Attention: Michael Lotito

Email: mlotito@apollo.com

 

Notice to Counterparty:

 

Wejo Limited

ABC Building

21-23 Quay Street

Manchester M3 4AE

Attention: Mina Bhama

Email: mina.bhama@wejo.com

 

Account Details

 

Account details for Seller: To be advised.

 

Account details for Counterparty: To be advised.

 

Other Provisions.

 

		(a)	Rule 10b5-1.

 

		(i)	Counterparty represents and warrants to Seller that Counterparty is not entering into the Transaction to create actual or apparent
trading activity in the Shares (or any security convertible into or exchangeable for the Shares) or to raise or depress or otherwise manipulate
the price of the Shares (or any security convertible into or exchangeable for the Shares) for the purpose of inducing the purchase or
sale of such securities or otherwise in violation of the Exchange Act, and Counterparty represents and warrants to Seller that Counterparty
has not entered into or altered, and agrees that Counterparty will not enter into or alter, any corresponding or hedging transaction or
position with respect to the Shares. Counterparty acknowledges that it is the intent of the parties that the Transaction comply with the
requirements of paragraphs (c)(1)(i)(A) and (B) of Rule 10b5-1 under the Exchange Act (“Rule 10b5-1”) and the Transaction
shall be interpreted to comply with the requirements of Rule 10b5-1(c).

 

		(ii)	Counterparty agrees that it will not seek to control or influence Seller’s decision to make any “purchases or sales”
(within the meaning of Rule 10b5-1(c)(1)(i)(B)(3)) under the Transaction, including, without limitation, Seller’s decision to enter
into any hedging transactions. Counterparty represents and warrants that it has consulted with its own advisors as to the legal aspects
of its adoption and implementation of this Confirmation and the Transaction under Rule 10b5-1.

 

    Page 9

     

    

 

		(iii)	Counterparty acknowledges and agrees that any amendment, modification, waiver or termination of this Confirmation must be effected
in accordance with the requirements for the amendment or termination of a “plan” as defined in Rule 10b5-1(c). Without limiting
the generality of the foregoing, Counterparty acknowledges and agrees that any such amendment, modification, waiver or termination shall
be made in good faith and not as part of a plan or scheme to evade the prohibitions of Rule 10b-5, and no such amendment, modification
or waiver shall be made at any time at which Counterparty or any officer, director, manager or similar person of Counterparty is aware
of any material non-public information regarding Counterparty or the Shares.

 

		(b)	Repurchase Notices. Counterparty shall, on any day on which Counterparty effects any repurchase of Shares, promptly
give Seller a written notice of such repurchase (a “Repurchase Notice”) on such day if following such repurchase, the
number of outstanding Shares as determined on such day is (i) less than the number of Shares outstanding that would result in the percentage
of total Shares outstanding represented by the number of Shares underlying the Transaction increasing by 0.10% (in the case of the first
such notice) or (ii) thereafter more than the number of Shares that would need to be repurchased to result in the percentage of total
Shares outstanding represented by the number of Shares underlying the Transaction increasing by a further 0.10% less than the number of
Shares included in the immediately preceding Repurchase Notice. Counterparty agrees to indemnify and hold harmless Seller and its affiliates
and their respective officers, directors, employees, affiliates, advisors, agents and controlling persons (each, an “Indemnified
Person”) from and against any and all losses (including losses relating to Seller’s hedging activities as a consequence
of remaining or becoming a Section 16 “insider” following the closing of the Business Combination, including without limitation,
any forbearance from hedging activities or cessation of hedging activities and any losses in connection therewith with respect to the
Transaction), claims, damages, judgments, liabilities and expenses (including reasonable attorney’s fees), joint or several, which
an Indemnified Person may become subject to, as a result of Counterparty’s failure to provide Seller with a Repurchase Notice on
the day and in the manner specified in this paragraph, and to reimburse, within thirty (30) days, upon written request, each of such Indemnified
Persons for any reasonable legal or other expenses incurred in connection with investigating, preparing for, providing testimony or other
evidence in connection with or defending any of the foregoing; provided, however, for the avoidance of doubt, Counterparty has no indemnification
or other obligations with respect to Seller becoming a Section 16 “insider” prior to the closing of the Business Combination.
If any suit, action, proceeding (including any governmental or regulatory investigation), claim or demand shall be brought or asserted
against the Indemnified Person as a result of Counterparty’s failure to provide Seller with a Repurchase Notice in accordance with
this paragraph, such Indemnified Person shall promptly notify Counterparty in writing, and Counterparty, upon request of the Indemnified
Person, shall retain counsel reasonably satisfactory to the Indemnified Person to represent the Indemnified Person and any others Counterparty
may designate in such proceeding and shall pay the fees and expenses of such counsel related to such proceeding. Counterparty shall not
be liable for any settlement of any proceeding contemplated by this paragraph that is effected without its written consent, but if settled
with such consent or if there be a final judgment for the plaintiff, Counterparty agrees to indemnify any Indemnified Person from and
against any loss or liability by reason of such settlement or judgment. Counterparty shall not, without the prior written consent of the
Indemnified Person, effect any settlement of any pending or threatened proceeding contemplated by this paragraph that is in respect of
which any Indemnified Person is or could have been a party and indemnity could have been sought hereunder by such Indemnified Person,
unless such settlement includes an unconditional release of such Indemnified Person from all liability on claims that are the subject
matter of such proceeding on terms reasonably satisfactory to such Indemnified Person. If the indemnification provided for in this paragraph
is unavailable to an Indemnified Person or insufficient in respect of any losses, claims, damages or liabilities referred to therein,
then Counterparty hereunder, in lieu of indemnifying such Indemnified Person thereunder, shall contribute to the amount paid or payable
by such Indemnified Person as a result of such losses, claims, damages or liabilities. The remedies provided for in this paragraph are
not exclusive and shall not limit any rights or remedies which may otherwise be available to any Indemnified Person at law or in equity.
The indemnity and contribution agreements contained in this paragraph shall remain operative and in full force and effect regardless of
the termination of the Transaction.

 

    Page 10

     

    

 

		(c)	Transfer or Assignment. The rights and duties under this Confirmation may not be transferred or assigned by any party
hereto without the prior written consent of the other party, such consent not to be unreasonably withheld; provided that Counterparty’s
consent shall not be required for any transfer by Seller, in whole or in part, to an affiliate or successor of Seller. If at any time
following the closing of the Business Combination at which (A) the Section 16 Percentage exceeds 9.9%, or (B) the Share Amount exceeds
the Applicable Share Limit (if any applies) (any such condition described in clause (A) or (B), an “Excess Ownership Position”),
Seller is unable after using its commercially reasonable efforts to effect a transfer or assignment of a portion of the Transaction to
a third party on pricing terms reasonably acceptable to Seller and within a time period reasonably acceptable to Seller such that no Excess
Ownership Position exists, then Seller may designate any Exchange Business Day as an Early Termination Date with respect to a portion
of the Transaction (the “Terminated Portion”), such that following such partial termination no Excess Ownership Position
exists. In the event that Seller so designates an Early Termination Date with respect to a portion of the Transaction, a portion of the
Shares with respect to the Transaction shall be delivered to Counterparty as if the Early Termination Date was the Valuation Date in respect
of a Transaction having terms identical to the Transaction and a Number of Shares equal to the number of Shares underlying the Terminated
Portion. The “Section 16 Percentage” as of any day is the fraction, expressed as a percentage, as determined by Seller,
(A) the numerator of which is the number of Shares that Seller and each person subject to aggregation of Shares with Seller under Section
13 or Section 16 of the Exchange Act and rules promulgated thereunder and all persons who may form a “group” (within the meaning
of Rule 13d-5(b)(1) of the Exchange Act) with Seller directly or indirectly beneficially own (as defined under Section 13 or Section 16
of the Exchange Act and rules promulgated thereunder) (the “Seller Group” ) and (B) the denominator of which is the
number of Shares outstanding.

 

The “Share Amount” as of any day is the
number of Shares that Seller and any person whose ownership position would be aggregated with that of Seller and any group (however designated)
of which Seller is a member (Seller or any such person or group, a “Seller Person”) under any law, rule, regulation,
regulatory order or organizational documents or contracts of Counterparty that are, in each case, applicable to ownership of Shares (“Applicable
Restrictions”), owns, beneficially owns, constructively owns, controls, holds the power to vote or otherwise meets a relevant
definition of ownership under any Applicable Restriction, as determined by Seller in its sole discretion.

 

The “Applicable Share Limit” means a
number of Shares equal to (A) the minimum number of Shares that could give rise to reporting or registration obligations or other requirements
(including obtaining prior approval from any person or entity) of a Seller Person, or could result in an adverse effect on a Seller Person,
under any Applicable Restriction, as determined by Seller in its sole discretion, minus (B) 0.1% of the number of Shares outstanding.

 

		(d)	Indemnification. Counterparty agrees to indemnify and hold harmless Seller, its affiliates and its assignees and their
respective directors, officers, employees, agents and controlling persons (each such person being an “Indemnified Party”)
from and against any and all losses (but not including financial losses to an Indemnified Party relating to the economic terms of the
Transaction provided that Counterparty performs its obligations under this Confirmation in accordance with its terms), claims, damages
and liabilities (or actions in respect thereof), joint or several, incurred by or asserted against such Indemnified Party arising out
of, in connection with, or relating to, any breach of any covenant or representation made by Counterparty in this Confirmation or the
ISDA Form; provided, however, Counterparty has no indemnification obligations with respect to any loss, claim, damage, liability or expense
related to the manner in which Seller sells the Subject Shares or any other Shares owned by Seller. Counterparty will not be liable under
the foregoing indemnification provision to the extent that any loss, claim, damage, liability or expense is found in a nonappealable judgment
by a court of competent jurisdiction to have resulted from Seller’s material breach of any covenant, representation or other obligation
in this Confirmation or the ISDA Form or from Seller’s willful misconduct, gross negligence or bad faith in performing the services
that are subject of the Transaction. If for any reason the foregoing indemnification is unavailable to any Indemnified Party or insufficient
to hold harmless any Indemnified Party, then Counterparty shall contribute, to the maximum extent permitted by law, to the amount paid
or payable by the Indemnified Party as a result of such loss, claim, damage or liability. In addition (and in addition to any other reimbursement
of legal fees and expenses contemplated by this Confirmation), Counterparty will reimburse any Indemnified Party for all expenses (including
reasonable counsel fees and expenses) as they are incurred in connection with the investigation of, preparation for or defense or settlement
of any pending or threatened claim or any action, suit or proceeding arising therefrom relating to such claims indemnifiable by Counterparty
hereunder, whether or not such Indemnified Party is a party thereto and whether or not such claim, action, suit or proceeding is initiated
or brought by or on behalf of Counterparty. Counterparty also agrees that no Indemnified Party shall have any liability to Counterparty
or any person asserting claims on behalf of or in right of Counterparty in connection with or as a result of any matter referred to in
this Confirmation except to the extent that any losses, claims, damages, liabilities or expenses incurred by Counterparty result from
such Indemnified Party’s breach of any covenant, representation or other obligation in this Confirmation or the ISDA Form or from
the gross negligence, willful misconduct or bad faith of the Indemnified Party. The provisions of this paragraph shall survive the completion
of the Transaction contemplated by this Confirmation and any assignment and/or delegation of the Transaction made pursuant to the ISDA
Form or this Confirmation shall inure to the benefit of any permitted assignee of Seller.

 

    Page 11

     

    

 

		(e)	Amendments to Equity Definitions.

 

		(i)	Section 11.2(a) of the Equity Definitions is hereby amended by (i) replacing the words “a diluting or concentrative” with
the word “an” and adding the phrase “or such Transaction” at the end thereof;

 

		(ii)	The first sentence of Section 11.2(c) of the Equity Definitions, prior to clause (A) thereof, is hereby amended to read as follows:
‘(c) If “Calculation Agent Adjustment” is specified as the Method of Adjustment in the related Confirmation of a Share
Option Transaction or Share Forward Transaction, then, following the announcement or occurrence of any Potential Adjustment Event, the
Calculation Agent will determine whether such Potential Adjustment Event has an economic effect on the Transaction and, if so, will (i)
make appropriate adjustment(s), if any, to any one or more of:’ and the portion of such sentence immediately preceding clause (ii)
thereof is hereby amended by deleting the words “diluting or concentrative”; and

 

		(iii)	Section 11.2(e)(vii) of the Equity Definitions is hereby amended by (i) replacing the words “a diluting or concentrative”
with the word “an” and (ii) adding the phrase “or the relevant Transaction” at the end thereof; and

 

		(iv)	Section 12.6(a)(ii) of the Equity Definitions is hereby amended by (i) deleting from the fourth line thereof the word “or”
after the word “official” and inserting a comma therefor, and (ii) deleting the semi-colon at the end of subsection (B) thereof
and inserting the following words therefor “or (C) the occurrence of any of the events specified in Section 5(a)(vii)(1) through
(9) of the ISDA Form with respect to that Issuer.”

 

		(v)	Section 12.9(b)(i) of the Equity Definitions is hereby amended by (i) replacing “either party may elect” with “Seller
may elect” and (ii) replacing “notice to the other party” with “notice to Counterparty” in the first sentence
of such section.

 

		(f)	Waiver of Jury Trial. Each party waives, to the fullest extent permitted by applicable law, any right it may have to
a trial by jury in respect of any suit, action or proceeding relating to the Transaction. Each party (i) certifies that no representative,
agent or attorney of either party has represented, expressly or otherwise, that such other party would not, in the event of such a suit,
action or proceeding, seek to enforce the foregoing waiver and (ii) acknowledges that it and the other party have been induced to enter
into the Transaction, as applicable, by, among other things, the mutual waivers and certifications provided herein.

 

		(g)	Tax Disclosure. Effective from the date of commencement of discussions concerning the Transaction, each party and each
of its employees, representatives, or other agents may disclose to any and all persons, without limitation of any kind, the tax treatment
and tax structure of the Transaction and all materials of any kind (including opinions or other tax analyses) that are provided to such
party relating to such tax treatment and tax structure.

 

		(h)	Securities Contract; Swap Agreement. The parties hereto intend for (i) the Transaction to be (a) a “securities
contract” as defined in the Bankruptcy Code, in which case each payment and delivery made pursuant to the Transaction is a “termination
value,” “payment amount” or “other transfer obligation” within the meaning of Section 362 of the Bankruptcy
Code and a “settlement payment,” within the meaning of Section 546 of the Bankruptcy Code, and (b) a “swap agreement”
as defined in the Bankruptcy Code, with respect to which each payment and delivery hereunder or in connection herewith is a “termination
value,” “payment amount” or “other transfer obligation” within the meaning of Section 362 of the Bankruptcy
Code and a “transfer,” as such term is defined in Section 101(54) of the Bankruptcy Code and a “payment or other transfer
of property” within the meaning of Sections 362 and 546 of the Bankruptcy Code, and the parties hereto to be entitled to the protections
afforded by, among other Sections, Sections 362(b)(6), 362(b)(17), 546(e), 546(g), 555 and 560 of the Bankruptcy Code, (ii) a party’s
right to liquidate, terminate and accelerate the Transaction and to exercise any other remedies upon the occurrence of any Event of Default
under the ISDA Form with respect to the other party to constitute a “contractual right” as described in the Bankruptcy Code,
and (iii) each payment and delivery of cash, securities or other property hereunder to otherwise constitute a “margin payment”
or “settlement payment” and a “transfer” as defined in the Bankruptcy Code.

 

		(i)	Process Agent. For the purposes of Section 13(c) of the ISDA Form:

 

Seller appoints as its Process Agent: None

 

Counterparty appoints as its Process Agent: None.

 

[Signature page follows]

 

    Page 12

     

    

 

Please confirm that the foregoing correctly sets forth the terms of
our agreement by executing a copy of this Confirmation and returning it to us at your earliest convenience.

 

Very truly yours,

 

Apollo A-N Credit Management, LLC as advisor
on behalf of each Seller listed on Annex I for which it is identified as the Investment Manager 

 

	By:	/s/ Joseph D. Glatt	 
	 	Name: Joseph D. Glatt	 
	 	Title: Vice President	 

 

Apollo Atlas Management, LLC as advisor on behalf of each Seller
listed on Annex I for which it is identified as the Investment Manager 

 

	By:	/s/ Joseph D. Glatt	 
	 	Name: Joseph D. Glatt	 
	 	Title: Vice President	 

 

Apollo ST Fund Management LLC as advisor on behalf of each Seller
listed on Annex I for which it is identified as the Investment Manager 

 

	By:	/s/ Joseph D. Glatt	 
	 	Name: Joseph D. Glatt	 
	 	Title: Vice President	 

 

Apollo PPF Credit Strategies Management, LLC as advisor on behalf
of each Seller listed on Annex I for which it is identified as the Investment Manager

 

	By:	/s/ Joseph D. Glatt	 
	 	Name: Joseph D. Glatt	 
	 	Title: Vice President	 

 

Apollo SPAC Management I, L.P., as advisor on behalf of each Seller
listed on Annex I for which it is identified as the Investment Manager

 

	By:	/s/ Joseph D. Glatt	 
	 	Name: Joseph D. Glatt	 
	 	Title: Authorized Signatory	 

 

Agreed and accepted by:

 

WEJO LIMITED

 

	By:	/s/ John Maxwell
	 
	 	Name: John Maxwell	 
	 	Title: Chief Financial Officer	 

 

    Page 13

     

    

 

SCHEDULE A

 

FORM OF PRICING DATE NOTICE

 

		Date:	[      ], 2021

 

		To:	Wejo Limited (“Counterparty”)

 

		Address:	ABC Building, 21-23 Quay Street, Manchester M3 4AE

 

		Phone:	+44 8002 343065

 

		From:	[Apollo A-N Credit Fund (Delaware), L.P./ Apollo Atlas Master Fund, LLC/ Apollo Credit Strategies Master Fund Ltd./ Apollo PPF Credit
Strategies, LLC/ Apollo SPAC Fund I, L.P] (“Seller”)

 

		Re:	OTC Equity Prepaid Forward Transaction

 

1.This Pricing Date Notice
supplements, forms part of, and is subject to the Confirmation Re: OTC Equity Prepaid Forward Transaction dated as of November 10, 2021
(the “Confirmation”) between Counterparty and Seller, as amended and supplemented from time to time. All provisions
contained in the Confirmation govern this Pricing Date Notice except as expressly modified below.

 

2.The
purpose of this Pricing Date Notice is to confirm certain terms and conditions of the Transaction entered into between Seller and Counterparty
pursuant to the Confirmation.

 

Pricing Date:         
, 2021

 

Number of Shares:[7,500,000] (the “Total Purchased Shares
Amount”)

 

    Page 14

     

    

 

ANNEX I

 

	
    

    SELLER
	INVESTMENT MANAGER
	Apollo A-N Credit Fund (Delaware), L.P.	Apollo A-N Credit Management, LLC
	Apollo Atlas Master Fund, LLC	Apollo Atlas Management, LLC
	Apollo Credit Strategies Master Fund Ltd.	Apollo ST Fund Management LLC
	Apollo PPF Credit Strategies, LLC	Apollo PPF Credit Strategies Management, LLC
	Apollo SPAC Fund I, L.P	Apollo SPAC Management I, L.P.

 

 

Page 15Exhibit 4.1

 

WARRANT AGREEMENT

 

THIS WARRANT AGREEMENT (this “Agreement”),
dated as of November 8, 2021, is by and between Apeiron Capital Investment Corp., a Delaware corporation (the “Company”),
and Continental Stock Transfer & Trust Company, a New York corporation, as warrant agent (the “Warrant Agent”,
also referred to herein as the “Transfer Agent”).

 

WHEREAS, the Company is engaged in an initial public
offering (the “Offering”) of units of the Company’s equity securities, each such unit comprised of one
share of Class A common stock of the Company, par value $0.0001 per share (“Common Stock”) and one-half
of one redeemable Public Warrant (as defined below) (the “Units”) and, in connection therewith, has determined
to issue and deliver up to 7,500,000 warrants (or up to 8,625,000 warrants if the Over-allotment Option is exercised in full) to public
investors in the Offering (the “Public Warrants”); and

 

WHEREAS, on November 8, 2021, the Company
entered into that certain Private Placement Warrants Purchase Agreement with Apeiron Capital Sponsor, LLC, a Delaware limited liability
company (the “Sponsor”), pursuant to which the Sponsor agreed to purchase 7,000,000 warrants (or 7,450,000 in
the event that the Over-allotment Option (as defined below) in connection with the Company’s Offering is exercised in full) simultaneously
with the closing of the Offering bearing the legend set forth in Exhibit B hereto (the “Private Placement Warrants”)
at a purchase price of $1.00 per Private Placement Warrant; and

 

WHEREAS, on November 8, 2021, the Company
entered into that certain Private Placement Warrants Purchase Agreement with Cantor Fitzgerald & Co. (“Cantor”),
pursuant to which Cantor and/or its designees agreed to purchase an aggregate of 750,000 Private Placement Warrants simultaneously with
the closing of the Offering bearing the legend set forth in Exhibit C hereto; and

 

WHEREAS, in order to finance the Company’s
transaction costs in connection with an intended initial Business Combination (as defined below), the Sponsor or an affiliate of the Sponsor
or certain of the Company’s executive officers and directors may, but are not obligated to, loan to the Company funds as the Company
may require, of which up to $1,500,000 of such loans may be convertible into up to an additional 1,500,000 warrants at a price of $1.00
per warrant (the “Working Capital Warrants”); and

 

WHEREAS, following consummation of the Offering,
the Company may issue additional warrants (“Post IPO Warrants”; together with the Private Placement Warrants,
the Working Capital Warrants and the Public Warrants, the “Warrants”) in connection with, or following the consummation
by the Company of, a Business Combination (defined below); and

 

WHEREAS, the Company has filed with the Securities
and Exchange Commission (the “Commission”) a registration statement on Form S-1, File No. 333-257369
(the “Registration Statement”) and prospectus (the “Prospectus”), for the registration,
under the Securities Act of 1933, as amended (the “Securities Act”), of the Units, the Public Warrants and the
Common Stock included in the Units; and

 

WHEREAS, the Company desires the Warrant Agent
to act on behalf of the Company, and the Warrant Agent is willing to so act, in connection with the issuance, registration, transfer,
exchange, redemption and exercise of the Warrants; and

 

WHEREAS, the Company desires to provide for the
form and provisions of the Warrants, the terms upon which they shall be issued and exercised, and the respective rights, limitation of
rights, and immunities of the Company, the Warrant Agent, and the holders of the Warrants; and

 

WHEREAS, all acts and things have been done and
performed which are necessary to make the Warrants, when executed on behalf of the Company and countersigned by or on behalf of the Warrant
Agent, as provided herein, the valid, binding and legal obligations of the Company, and to authorize the execution and delivery of this
Agreement.

 

    1

     

    

 

NOW, THEREFORE, in consideration of the mutual agreements
herein contained, the parties hereto agree as follows:

 

1.            Appointment
of Warrant Agent. The Company hereby appoints the Warrant Agent to act as agent for the Company for the Warrants, and the Warrant
Agent hereby accepts such appointment and agrees to perform the same in accordance with the terms and conditions set forth in this Agreement.

 

2.            Warrants.

 

2.1           Form of
Warrant. Each Warrant shall be issued in registered form only, and, if a physical certificate is issued, shall be in substantially
the form of Exhibit A hereto, the provisions of which are incorporated herein and shall be signed by, or bear the facsimile
signature of, the Chairman of the Board, President, Chief Executive Officer, Chief Financial Officer, Secretary or other principal officer
of the Company. In the event the person whose facsimile signature has been placed upon any Warrant shall have ceased to serve in the capacity
in which such person signed the Warrant before such Warrant is issued, it may be issued with the same effect as if he or she had not ceased
to be such at the date of issuance.

 

2.2           Effect
of Countersignature. If a physical certificate is issued, unless and until countersigned by the Warrant Agent pursuant to this Agreement,
a Warrant certificate shall be invalid and of no effect and may not be exercised by the holder thereof.

 

2.3           Registration.

 

2.3.1            Warrant
Register. The Warrant Agent shall maintain books (the “Warrant Register”) for the registration of original
issuance and the registration of transfer of the Warrants. Upon the initial issuance of the Warrants, the Warrant Agent shall issue and
register the Warrants in the names of the respective holders thereof in such denominations and otherwise in accordance with instructions
delivered to the Warrant Agent by the Company. All of the Public Warrants shall initially be represented by one or more book-entry certificates
(each, a “Book-Entry Warrant Certificate”) deposited with The Depository Trust Company (the “Depositary”)
and registered in the name of Cede & Co., a nominee of the Depositary. Ownership of beneficial interests in the Public Warrants
shall be shown on, and the transfer of such ownership shall be effected through, records maintained by (i) the Depositary or its
nominee for each Book-Entry Warrant Certificate, or (ii) institutions that have accounts with the Depositary (each such institution,
with respect to a Warrant in its account, a “Participant”).

 

If the Depositary subsequently ceases to make its
book-entry settlement system available for the Public Warrants, the Company may instruct the Warrant Agent regarding making other arrangements
for book-entry settlement. In the event that the Public Warrants are not eligible for, or it is no longer necessary to have the Public
Warrants available in, book-entry form, the Warrant Agent shall provide written instructions to the Depositary to deliver to the Warrant
Agent for cancellation each Book-Entry Warrant Certificate, and the Company shall instruct the Warrant Agent to deliver to the Depositary
definitive certificates in physical form evidencing such Warrants (“Definitive Warrant Certificate”). Such Definitive
Warrant Certificate shall be in the form annexed hereto as Exhibit A, with appropriate insertions, modifications and omissions,
as provided above.

 

2.3.2            Registered
Holder. Prior to due presentment for registration of transfer of any Warrant, the Company and the Warrant Agent may deem and
treat the person in whose name such Warrant is registered in the Warrant Register (the “Registered
Holder”) as the absolute owner of such Warrant and of each Warrant represented thereby (notwithstanding any notation
of ownership or other writing on a Definitive Warrant Certificate made by anyone other than the Company or the Warrant Agent), for
the purpose of any exercise thereof, and for all other purposes, and neither the Company nor the Warrant Agent shall be affected by
any notice to the contrary.

 

    2

     

    

 

2.4           Detachability
of Warrants. The Common Stock and Public Warrants comprising the Units shall begin separate trading on the 52nd day following the
date of the Prospectus or, if such 52nd day is not on a day, other than a Saturday, Sunday or federal holiday, on which banks in New York
City are generally open for normal business (a “Business Day”), then on the immediately succeeding Business
Day following such date, or earlier (the “Detachment Date”) with the consent of Cantor Fitzgerald &
Co., as representative of the several underwriters (the “Representative”), but in no event shall the Common
Stock and the Public Warrants comprising the Units be separately traded until (A) the Company has filed a current report on Form 8-K
with the Commission containing an audited balance sheet reflecting the receipt by the Company of the gross proceeds of the Offering, including
the proceeds received by the Company from the exercise by the underwriters of their right to purchase additional Units in the Offering
(the “Over-Allotment Option”), if the Over- Allotment Option is exercised prior to the filing of the Form 8-K,
and (B) the Company issues a press release and files with the Commission a current report on Form 8-K announcing when such separate
trading shall begin.

 

2.5           No
Fractional Warrants Other Than as Part of Units. The Company shall not issue fractional Warrants other than as part of the Units,
each of which is comprised of one share of Common Stock and one-half of one Public Warrant. If, upon the detachment of Public Warrants
from Units or otherwise, a holder of Warrants would be entitled to receive a fractional Warrant, the Company shall round down to the nearest
whole number the number of Warrants to be issued to such holder.

 

2.6           Private
Placement Warrants and Working Capital Warrants. The Private Placement Warrants and the Working Capital Warrants shall be
identical to the Public Warrants, except that so long as they are held by the Sponsor, Cantor and/or its designees or any Permitted
Transferees (as defined below), as applicable, the Private Placement Warrants and the Working Capital Warrants: (i) may be
exercised for cash or on a cashless basis, pursuant to subsection 3.3.1(c) hereof,
(ii) may not be transferred, assigned or sold until thirty
(30) days after the completion by the Company of an initial Business Combination (as defined below), and (iii) shall not be
redeemable by the Company; provided, however, that in the case of (ii) the Private Placement Warrants and the
Working Capital Warrants and any shares of Common Stock held by the Sponsor, Cantor and/or its designees, or any Permitted
Transferees, as applicable, and issued upon exercise of the Private Placement Warrants and the Working Capital Warrants may be
transferred by the holders thereof:

 

(a)            to
the Company’s officers or directors, any affiliate or family member of any of the Company’s officers or directors, any affiliate
of the Sponsor or to any member(s) of the Sponsor or any of their affiliates, officers, directors and direct and indirect equityholders
of Cantor and/or its designees;

 

(b)            in
the case of an individual, by gift to a member such individual’s immediate family or to a trust, the beneficiary of which is a member
of such individual’s immediate family, an affiliate of such individual or to a charitable organization;

 

(c)           in
the case of an individual, by virtue of the laws of descent and distribution upon death of such person;

 

(d)           
in the case of an individual, pursuant to a qualified domestic relations order;

 

(e)            by
private sales or transfers made in connection with the consummation of an initial Business Combination at prices no greater than the price
at which the Warrants were originally purchased;

 

(f)             in
the event of the Company’s liquidation prior to consummation of the Company’s Business Combination; or

 

    3

     

    

(g)            by
virtue of the laws of the State of Delaware or the Sponsor’s limited liability company agreement upon dissolution of the Sponsor
or the organizational documents of Cantor upon dissolution of Cantor; provided, however, that, in each case these permitted transferees
(the “Permitted Transferees”) must enter into a written agreement with the Company agreeing to be bound by
the transfer restrictions in this Agreement. Notwithstanding the foregoing, with respect to any Private Placement Warrants held by Cantor
and/or its designees, in addition to the foregoing restriction on transfer of the Private Placement Warrants, the Private Placement Warrants
purchased by Cantor and/or its designees shall not be sold during the Offering, or sold, transferred, assigned, pledged or hypothecated
for a period of 180 days immediately following the date of effectiveness of the Registration Statement or commencement of sales of the
Offering, except to any member participating in the Offering and the officers or partners thereof. Additionally, the Private Placement
Warrants purchased by Cantor and/or its designees shall not be the subject of any hedging, short sale, derivative, put or call transaction
that would result in the effective economic disposition of the securities by any person for a period of 180 days immediately following
the date of effectiveness of the Registration Statement or commencement of sales of the Offering.

 

2.7          Working
Capital Warrants. The Working Capital Warrants shall be identical to the Private Placement Warrants.

 

2.8           Post-IPO
Warrants. The Post-IPO Warrants, when and if issued, shall have the same terms and be in the same form as the Public Warrants except
as may be agreed upon by the Company.

 

3.            Terms
and Exercise of Warrants.

 

3.1          Warrant
Price. Each whole Warrant shall entitle the Registered Holder thereof, subject to the provisions of such Warrant and of this Agreement,
to purchase from the Company the number of shares of Common Stock stated therein, at the price of $11.50 per share, subject to the adjustments
provided in Section 4 hereof and in the last sentence of this Section 3.1. The term “Warrant Price”
as used in this Agreement shall mean the price per share at which shares of Common Stock may be purchased at the time a Warrant is exercised.
The Company in its sole discretion may lower the Warrant Price at any time prior to the Expiration Date (as defined below) for a period
of not less than twenty (20) Business Days; provided, that the Company shall provide at least five (5) days’ prior written
notice of such reduction to Registered Holders of the Warrants; and provided further, that any such reduction shall be identical among
all of the Warrants.

 

3.2          Duration
of Warrants. A Warrant may be exercised only during the period (the “Exercise Period”) commencing on
the later of: (i) the date that is thirty (30) days after the first date on which the Company completes a merger, capital stock
exchange, asset acquisition, stock purchase, reorganization or similar business combination, involving the Company and one or more
businesses (a “Business Combination”), or (ii) the date that is twelve (12) months from the date of
the closing of the Offering, and terminating at 5:00 p.m., New York City time on the earlier to occur of: (x) the date that is
five (5) years after the date on which the Company completes its initial Business Combination, (y) the liquidation of the
Company if the Company fails to complete a Business Combination, or (z) other than with respect to the Private Placement
Warrants and the Working Capital Warrants to the extent then held by the original purchasers thereof or their Permitted Transferees,
the Redemption Date (as defined below) as provided in Section 6.2 hereof (the Expiration Date”); provided, however,
that the exercise of any Warrant shall be subject to the satisfaction of any applicable conditions, as set forth in subsection
3.3.2 below with respect to an effective registration statement. Except with respect to the right to receive the Redemption
Price (as defined below) (other than with respect to a Private Placement Warrant or a Working Capital Warrant) to the extent then
held by the original purchasers thereof or their Permitted Transferees in the event of a redemption (as set forth in Section 6
hereof), each outstanding Warrant (other than a Private Placement Warrant or a Working Capital Warrant to the extent then held by
the original purchasers thereof or their Permitted Transferees in the event of a redemption) not exercised on or before the
Expiration Date shall become void, and all rights thereunder and all rights in respect thereof under this Agreement shall cease at
5:00 p.m. New York City time on the Expiration Date. The Company in its sole discretion may extend the duration of the Warrants
by delaying the Expiration Date; provided, that the Company shall provide at least twenty (20) days prior written notice of
any such extension to Registered Holders of the Warrants and, provided further that any such extension shall be identical in
duration among all the Warrants. Notwithstanding anything to the contrary contained herein, for so long as any Private Placement
Warrant is held by Cantor and/or its designees, such Private Placement Warrant may not be exercised after five years from the
effective date of the Registration Statement.

 

    4

     

    

 

3.3          Exercise
of Warrants.

 

3.3.1         Payment.
Subject to the provisions of the Warrant and this Agreement, a Warrant may be exercised by the Registered Holder thereof by delivering
to the Warrant Agent at its corporate trust department (i) the Definitive Warrant Certificate evidencing the Warrants to be exercised,
or, in the case of a Book-Entry Warrant Certificate, the Warrants to be exercised (the “Book-Entry Warrants”)
on the records of the Depositary to an account of the Warrant Agent at the Depositary designated for such purposes in writing by the Warrant
Agent to the Depositary from time to time, (ii) an election to purchase (“Election to Purchase”) shares
of Common Stock pursuant to the exercise of a Warrant, properly completed and executed by the Registered Holder on the reverse of the
Definitive Warrant Certificate or, in the case of a Book-Entry Warrant Certificate, properly delivered by the Participant in accordance
with the Depositary’s procedures, and (iii) payment in full of the Warrant Price for each full share of Common Stock as to
which the Warrant is exercised and any and all applicable taxes due in connection with the exercise of the Warrant, the exchange of the
Warrant for the shares of Common Stock and the issuance of such shares of Common Stock, as follows:

 

(a)            by
certified check payable to the order of the Warrant Agent or by wire transfer;

 

    5

     

    

 

(b)           in
the event of a redemption pursuant to Section 6 hereof in which the Company’s board of directors (the “Board”)
has elected to require all holders of the Warrants to exercise such Warrants on a “cashless basis,” by surrendering the Warrants
for that number of shares of Common Stock equal to the quotient obtained by dividing (x) the product of the number of shares of Common
Stock underlying the Warrants, multiplied by the difference between the Warrant Price and the “Fair Market Value”, as defined
in this subsection 3.3.1(b) by (y) the Fair Market Value. Solely for purposes of this subsection 3.3.1(b) and
Section 6.3, the “Fair Market Value” shall mean the average last sale price of the Common Stock for the ten (10) trading
days ending on the third trading day prior to the date on which the notice of redemption is sent to the holders of the Warrants, pursuant
to Section 6 hereof;

 

(c)  with respect to any Private Placement Warrant
or Working Capital Warrant, so long as such Private Placement Warrant or Working Capital Warrant is held by the Sponsor, Cantor and/or
its designees, or a Permitted Transferee, as applicable, by surrendering the Warrants for that number of shares of Common Stock equal
to the quotient obtained by dividing (x) the product of the number of shares of Common Stock underlying the Warrants, multiplied
by the difference between the Warrant Price and the “Fair Market Value”, as defined in this subsection 3.3.1(c), by
(y) the Fair Market Value. Solely for purposes of this subsection 3.3.1(c), the “Fair Market Value” shall mean
the average reported last sale price of the Common Stock for the ten (10) trading days ending on the third trading day prior to the
date on which notice of exercise of the Warrant is sent to the Warrant Agent; or

 

(d)           as
provided in Section 7.4 hereof.

 

3.3.2        Issuance
of Shares of Common Stock on Exercise. As soon as practicable after the exercise of any Warrant and the clearance of the funds in
payment of the Warrant Price (if payment is pursuant to subsection 3.3.1(a)), the Company shall issue to the Registered Holder
of such Warrant a book-entry position or certificate, as applicable, for the number of full shares of Common Stock to which he, she or
it is entitled, registered in such name or names as may be directed by him, her or it, and if such Warrant shall not have been exercised
in full, a new book-entry position or countersigned Warrant, as applicable, for the number of shares of Common Stock as to which such
Warrant shall not have been exercised. If fewer than all the Warrants evidenced by a Book-Entry Warrant Certificate are exercised, a notation
shall be made to the records maintained by the Depositary, its nominee for each Book-Entry Warrant Certificate, or a Participant, as appropriate,
evidencing the balance of the Warrants remaining after such exercise. Notwithstanding the foregoing, the Company shall not be obligated
to deliver any shares of Common Stock pursuant to the exercise of a Warrant and shall have no obligation to settle such Warrant exercise
unless a registration statement under the Securities Act with respect to the shares of Common Stock underlying the Public Warrants is
then effective and a prospectus relating thereto is current, subject to the Company’s satisfying its obligations under Section 7.4.
No Warrant shall be exercisable and the Company shall not be obligated to issue shares of Common Stock upon exercise of a Warrant unless
the Common Stock issuable upon such Warrant exercise has been registered, qualified or deemed to be exempt from registration or qualification
under the securities laws of the state of residence of the Registered Holder of the Warrants, except pursuant to Section 7.4.
In the event that the conditions in the two immediately preceding sentences are not satisfied with respect to a Warrant, the holder of
such Warrant shall not be entitled to exercise such Warrant and such Warrant may have no value and expire worthless, in which case the
purchaser of a Unit containing such Public Warrants shall have paid the full purchase price for the Unit solely for the shares of Common
Stock underlying such Unit. In no event will the Company be required to net cash settle the Warrant exercise. The Company may require
holders of Public Warrants to settle the Warrant on a “cashless basis” pursuant to subsection 3.3.1(b) and Section 7.4.
If, by reason of any exercise of Warrants on a “cashless basis”, the holder of any Warrant would be entitled, upon the exercise
of such Warrant, to receive a fractional interest in a share of Common Stock, the Company shall round down to the nearest whole number,
the number of shares of Common Stock to be issued to such holder.

 

    6

     

    

 

3.3.3            Valid
Issuance. All shares of Common Stock issued upon the proper exercise of a Warrant in conformity with this Agreement shall be validly
issued, fully paid and non-assessable.

 

3.3.4            Date
of Issuance. Each person in whose name any book-entry position or certificate, as applicable, for shares of Common Stock is issued
shall for all purposes be deemed to have become the holder of record of such shares of Common Stock on the date on which the Warrant,
or book- entry position representing such Warrant, was surrendered and payment of the Warrant Price was made, irrespective of the date
of delivery of such certificate in the case of a certificated Warrant, except that, if the date of such surrender and payment is a date
when the share transfer books of the Company or book- entry system of the Warrant Agent are closed, such person shall be deemed to have
become the holder of such shares of Common Stock at the close of business on the next succeeding date on which the share transfer books
or book-entry system are open.

 

3.3.5            Maximum
Percentage. A holder of a Warrant may notify the Company in writing in the event it elects to be subject to the provisions
contained in this subsection 3.3.5; however, no holder of a Warrant shall be subject to this subsection 3.3.5
unless he, she or it makes such election. If the election is made by a holder, the Warrant Agent shall not effect the exercise of
the holder’s Warrant, and such holder shall not have the right to exercise such Warrant, to the extent that after giving
effect to such exercise, such person (together with such person’s affiliates), to the Warrant Agent’s actual knowledge,
would beneficially own in excess of 4.9% or 9.8% (or such other amount as a holder may specify)(the “Maximum
Percentage”) of the shares of Common Stock outstanding immediately after giving effect to such exercise. For purposes
of the foregoing sentence, the aggregate number of shares of Common Stock beneficially owned by such person and its affiliates shall
include the number of shares of Common Stock issuable upon exercise of the Warrant with respect to which the determination of such
sentence is being made, but shall exclude shares of Common Stock that would be issuable upon (x) exercise of the remaining,
unexercised portion of the Warrant beneficially owned by such person and its affiliates and (y) exercise or conversion of the
unexercised or unconverted portion of any other securities of the Company beneficially owned by such person and its affiliates
(including, without limitation, any convertible notes or convertible preferred stock or warrants) subject to a limitation on
conversion or exercise analogous to the limitation contained herein. Except as set forth in the preceding sentence, for purposes of
this paragraph, beneficial ownership shall be calculated in accordance with Section  13(d) of the Securities Exchange Act
of 1934, as amended (the “Exchange Act”). For purposes of the Warrant, in determining the number of
outstanding shares of Common Stock, the holder may rely on the number of outstanding shares of Common Stock as reflected in
(1) the Company’s most recent annual report on Form 10-K, quarterly report on Form 10-Q, current report on
Form 8-K or other public filing with the Commission as the case may be, (2) a more recent public announcement by the
Company or (3) any other notice by the Company or the Transfer Agent setting forth the number of shares of Common Stock
outstanding. For any reason at any time, upon the written request of the holder of the Warrant, the Company shall, within two
(2) Business Days, confirm orally and in writing to such holder the number of shares of Common Stock then outstanding. In any
case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of
equity securities of the Company by the holder and its affiliates since the date as of which such number of outstanding shares of
Common Stock was reported. By written notice to the Company, the holder of a Warrant may from time to time increase or decrease the
Maximum Percentage applicable to such holder to any other percentage specified in such notice; provided, however, that
any such increase shall not be effective until the sixty-first (61st) day after such notice is delivered to the Company.

 

    7

     

    

 

	 	4.	Adjustments.

 

	 	4.1	Stock Dividends.

 

4.1.1            Split-Ups.
If after the date hereof, and subject to the provisions of Section 4.6 below, the number of outstanding shares of Common Stock
is increased by a stock dividend payable in shares of Common Stock, or by a split-up of shares of Common Stock or other similar event,
then, on the effective date of such stock dividend, split-up or similar event, the number of shares of Common Stock issuable on exercise
of each Warrant shall be increased in proportion to such increase in the outstanding shares of Common Stock. A rights offering to holders
of the Common Stock entitling holders to purchase shares of Common Stock at a price less than the “Fair Market Value” (as
defined below) shall be deemed a stock dividend of a number of shares of Common Stock equal to the product of (i) the number of shares
of Common Stock actually sold in such rights offering (or issuable under any other equity securities sold in such rights offering that
are convertible into or exercisable for the Common Stock) and (ii) one (1) minus the quotient of (x) the price per share
of Common Stock paid in such rights offering divided by (y) the Fair Market Value. For purposes of this subsection 4.1.1,
(i) if the rights offering is for securities convertible into or exercisable for Common Stock, in determining the price payable for
Common Stock, there shall be taken into account any consideration received for such rights, as well as any additional amount payable upon
exercise or conversion and (ii) “Fair Market Value” means the volume weighted average price of the Common Stock as reported
during the ten (10) trading day period ending on the trading day prior to the first date on which the shares of Common Stock trade
on the applicable exchange or in the applicable market, regular way, without the right to receive such rights.

 

4.1.2            Extraordinary
Dividends. If the Company, at any time while the Warrants are outstanding and unexpired, shall pay a dividend or make a
distribution in cash, securities or other assets to the holders of the Common Stock on account of such shares of Common Stock (or
other shares of the Company’s capital stock into which the Warrants are convertible), other than (a) as described in subsection
4.1.1 above, (b) Ordinary Cash Dividends (as defined below), (c) to satisfy the redemption rights of the holders of
the Common Stock in connection with a proposed initial Business Combination, (d) as a result of the repurchase of shares of
Common Stock by the Company if a proposed Business Combination is presented to the stockholders of the Company for approval,
(e) to satisfy the redemption rights of the holders of Common Stock in connection with a stockholder vote to amend the
Company’s amended and restated certificate of incorporation to modify the substance or timing of the Company’s
obligation to redeem 100% of the public shares of Common Stock if the Company does not complete the Business Combination within the
period set forth in the Company’s amended and restated certificate of incorporation or (f) in connection with the
redemption of public shares of Common Stock upon the failure of the Company to complete its initial Business Combination and any
subsequent distribution of its assets upon its liquidation (any such non-excluded event being referred to herein as an
 “Extraordinary Dividend”), then the Warrant Price shall be decreased, effective immediately after the
effective date of such Extraordinary Dividend, by the amount of cash and/or the fair market value (as determined by the Board, in
good faith) of any securities or other assets paid on each share of Common Stock in respect of such Extraordinary Dividend. For
purposes of this subsection 4.1.2, “Ordinary Cash Dividends” means any cash dividend or cash
distribution which, when combined on a per share basis, with the per share amounts of all other cash dividends and cash
distributions paid on the Common Stock during the 365-day period ending on the date of declaration of such dividend or distribution
(as adjusted to appropriately reflect any of the events referred to in other subsections of this Section 4 and excluding
cash dividends or cash distributions that resulted in an adjustment to the Warrant Price or to the number of shares of Common Stock
issuable on exercise of each Warrant) does not exceed $0.50 (being 5% of the offering price of the Units in the Offering).

 

4.2            Aggregation
of Shares. If after the date hereof, and subject to the provisions of Section 4.6 hereof, the number of outstanding shares
of Common Stock is decreased by a consolidation, combination, reverse stock split or reclassification of shares of Common Stock or other
similar event, then, on the effective date of such consolidation, combination, reverse stock split, reclassification or similar event,
the number of shares of Common Stock issuable on exercise of each Warrant shall be decreased in proportion to such decrease in outstanding
shares of Common Stock.

 

    8

     

    

 

	 	4.3	Adjustments in Exercise Price.

 

	 	4.3.1	Whenever the number of shares
    of Common Stock purchasable upon the exercise of the Warrants is adjusted, as provided in subsection 4.1.1 or Section 4.2 above, the Warrant
Price shall be adjusted (to the nearest cent) by multiplying such Warrant Price immediately prior to such adjustment by a fraction (x) the
numerator of which shall be the number of shares of Common Stock purchasable upon the exercise of the Warrants immediately prior to such
adjustment, and (y) the denominator of which shall be the number of shares of Common Stock so purchasable immediately thereafter.

 

    9

     

    

 

4.3.2            If
(i) the Company issues additional shares of Common Stock or securities convertible into or exercisable or exchangeable for shares
of Common Stock for capital raising purposes in connection with the closing of its initial Business Combination at an issue price or effective
issue price of less than $9.20 per share of Common Stock, with such issue price or effective issue price to be determined in good faith
by the Board (and in the case of any such issuance to the Sponsor or its affiliates, without taking into account any founder shares held
by such holder or affiliates, as applicable, prior to such issuance) (the “New Issuance Price”), (ii) the
aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for
the funding of the initial Business Combination on the date of the consummation thereof (net of redemptions) and (iii) the volume
weighted average trading price of the Common Stock during the 20 trading day period starting on the trading day prior to the day on which
the Company consummates the initial Business Combination (such price, the "Market Value") is below $9.20 per share, then the
Warrant Price shall be adjusted (to the nearest cent) to be equal to 115% of the greater of the Market Value and the New Issuance Price
and the Redemption Trigger Price (as defined below) shall be adjusted (to the nearest cent) to be equal to 180% of the greater of the
Market Value and the Newly Issued Price.

 

 

4.4            Replacement
of Securities upon Reorganization, etc. In case of any reclassification or reorganization of the outstanding shares of
Common Stock (other than a change under subsections 4.1.1 or 4.1.2 or Section 4.2 hereof or that solely
affects the par value of such shares of Common Stock), or in the case of any merger or consolidation of the Company with or into
another entity or conversion of the Company as another entity (other than a consolidation or merger in which the Company is the
continuing corporation and that does not result in any reclassification or reorganization of the outstanding shares of Common
Stock), or in the case of any sale or conveyance to another entity of the assets or other property of the Company as an entirety or
substantially as an entirety in connection with which the Company is dissolved, the holders of the Warrants shall thereafter have
the right to purchase and receive, upon the basis and upon the terms and conditions specified in the Warrants and in lieu of the
shares of Common Stock of the Company immediately theretofore purchasable and receivable upon the exercise of the rights represented
thereby, the kind and amount of shares of stock or other securities or property (including cash) receivable upon such
reclassification, reorganization, merger or consolidation, or upon a dissolution following any such sale or transfer, that the
holder of the Warrants would have received if such holder had exercised his, her or its Warrant(s) immediately prior to such
event (the “Alternative Issuance” ); provided, however, that in connection with the closing
of any such consolidation, merger, sale or conveyance, the successor or purchasing entity shall execute an amendment hereto with the
Warrant Agent providing for delivery of such Alternative Issuance; provided, further, that (i)  if the holders of
the Common Stock were entitled to exercise a right of election as to the kind or amount of securities, cash or other assets
receivable upon such consolidation or merger, then the kind and amount of securities, cash or other assets constituting the
Alternative Issuance for which each Warrant shall become exercisable shall be deemed to be the weighted average of the kind and
amount received per share by the holders of the Common Stock in such consolidation or merger that affirmatively make such election,
and (ii) if a tender, exchange or redemption offer shall have been made to and accepted by the holders of the Common Stock
(other than a tender, exchange or redemption offer made by the Company in connection with redemption rights held by stockholders of
the Company as provided for in the Company’s amended and restated certificate of incorporation or as a result of the
repurchase of shares of Common Stock by the Company if a proposed initial Business Combination is presented to the stockholders of
the Company for approval) under circumstances in which, upon completion of such tender or exchange offer, the maker thereof,
together with members of any group (within the meaning of Rule 13d-5(b)(1) under the Exchange Act (or any successor rule))
of which such maker is a part, and together with any affiliate or associate of such maker (within the meaning of Rule 12b-2
under the Exchange Act (or any successor rule)) and any members of any such group of which any such affiliate or associate is a
part, own beneficially (within the meaning of Rule 13d-3 under the Exchange Act (or any successor rule)) more than 50% of the
outstanding shares of Common Stock, the holder of a Warrant shall be entitled to receive as the Alternative Issuance, the highest
amount of cash, securities or other property to which such holder would actually have been entitled as a stockholder if such Warrant
holder had exercised the Warrant prior to the expiration of such tender or exchange offer, accepted such offer and all of the Common
Stock held by such holder had been purchased pursuant to such tender or exchange offer, subject to adjustments (from and after the
consummation of such tender or exchange offer) as nearly equivalent as possible to the adjustments provided for in this Section 4; provided, further,
that if less than 70% of the consideration receivable by the holders of the Common Stock in the applicable event is payable in the
form of common stock in the successor entity that is listed for trading on a national securities exchange or is quoted in an
established over-the- counter market, or is to be so listed for trading or quoted immediately following such event, and if the
Registered Holder properly exercises the Warrant within thirty (30) days following the public disclosure of the consummation of such
applicable event by the Company pursuant to a Current Report on Form 8-K filed with the Commission, the Warrant Price shall be
reduced by an amount (in dollars) (but in no event less than zero) equal to the difference of (i) the Warrant Price in effect
prior to such reduction minus (ii) (A) the Per Share Consideration (as defined below) minus (B) the Black-Scholes
Warrant Value (as defined below). The “Black-Scholes Warrant Value” means the value of a Warrant
immediately prior to the consummation of the applicable event based on the Black-Scholes Warrant Model for a Capped American Call on
Bloomberg Financial Markets (“Bloomberg”). For purposes of calculating such amount,
(1) Section 6 of this Agreement shall be taken into account, (2) the price of each share of Common Stock shall
be the volume weighted average price of the Common Stock as reported during the ten (10) trading day period ending on the
trading day prior to the effective date of the applicable event, (3) the assumed volatility shall be the 90 day volatility
obtained from the HVT function on Bloomberg determined as of the trading day immediately prior to the day of the announcement of the
applicable event, and (4) the assumed risk-free interest rate shall correspond to the U.S. Treasury rate for a period equal to
the remaining term of the Warrant. “Per Share Consideration” means (i) if the consideration paid to
holders of the Common Stock consists exclusively of cash, the amount of such cash per share of Common Stock, and (ii) in all
other cases, the amount of cash per share of Common Stock, if any, plus the volume weighted average price of the Common Stock as
reported during the ten (10) trading day period ending on the trading day prior to the effective date of the applicable event.
If any reclassification or reorganization also results in a change in shares of Common Stock covered by subsection 4.1.1,
then such adjustment shall be made pursuant to subsection 4.1.1 or Sections 4.2, 4.3 and this Section 4.4.
The provisions of this Section 4.4 shall similarly apply to successive reclassifications, reorganizations, mergers or
consolidations, sales or other transfers. In no event will the Warrant Price be reduced to less than the par value per share
issuable upon exercise of the Warrant.

 

    10

     

    

 

  

4.5            Notices
of Changes in Warrant. Upon every adjustment of the Warrant Price or the number of shares of Common Stock issuable upon exercise
of a Warrant, the Company shall give written notice thereof to the Warrant Agent, which notice shall state the Warrant Price
resulting from such adjustment and the increase or decrease, if any, in the number of shares of Common Stock purchasable at such
price upon the exercise of a Warrant, setting forth in reasonable detail the method of calculation and the facts upon which such
calculation is based. Upon the occurrence of any event specified in Sections 4.1, 4.2, 4.3 or 4.4, the
Company shall give written notice of the occurrence of such event to each holder of a Warrant, at the last address set forth for
such holder in the Warrant Register, of the record date or the effective date of the event. Failure to give such notice, or any
defect therein, shall not affect the legality or validity of such event.

 

4.6            No
Fractional Shares. Notwithstanding any provision contained in this Agreement to the contrary, the Company shall not issue fractional
shares of Common Stock upon the exercise of Warrants. If, by reason of any adjustment made pursuant to this Section 4, the
holder of any Warrant would be entitled, upon the exercise of such Warrant, to receive a fractional interest in a share, the Company shall,
upon such exercise, round down to the nearest whole number the number of shares of Common Stock to be issued to such holder.

 

4.7            Form of
Warrant. The form of Warrant need not be changed because of any adjustment pursuant to this Section 4, and Warrants issued
after such adjustment may state the same Warrant Price and the same number of shares of Common Stock as is stated in the Warrants initially
issued pursuant to this Agreement; provided, however, that the Company may at any time in its sole discretion make any change
in the form of Warrant that the Company may deem appropriate and that does not affect the substance thereof, and any Warrant thereafter
issued or countersigned, whether in exchange or substitution for an outstanding Warrant or otherwise, may be in the form as so changed.

 

4.8            Other
Events. In case any event shall occur affecting the Company as to which none of the provisions of preceding subsections of this Section 4
are strictly applicable, but which would require an adjustment to the terms of the Warrants in order to (i) avoid an adverse impact
on the Warrants and (ii) effectuate the intent and purpose of this Section 4, then, in each such case, the Company shall
appoint a firm of independent public accountants, investment banking or other appraisal firm of recognized national standing, which shall
give its opinion as to whether or not any adjustment to the rights represented by the Warrants is necessary to effectuate the intent and
purpose of this Section 4 and, if they determine that an adjustment is necessary, the terms of such adjustment, provided,
however, that under no circumstances shall the Warrants be adjusted pursuant to this Section 4.8 as a result of any issuance of securities
in connection with the Business Combination. The Company shall adjust the terms of the Warrants in a manner that is consistent with any
adjustment recommended in such opinion.

 

    11

     

    

 

4.9            No
Adjustment. For the avoidance of doubt, no adjustment shall be made to the terms of the Warrants solely as a result of an adjustment
to the conversion ratio of the Company’s Class B common stock (the “Class B Common Stock”) into
shares of Common Stock or the conversion of the shares of Class B Common Stock into shares of Common Stock, in each case, pursuant
to the Company’s Charter, as amended from time to time.

 

5.             Transfer and Exchange of Warrants.

 

5.1            Registration
of Transfer. The Warrant Agent shall register the transfer, from time to time, of any outstanding Warrant upon the Warrant Register,
upon surrender of such Warrant for transfer, in the case of certificated Warrants, properly endorsed with signatures properly guaranteed
and accompanied by appropriate instructions for transfer. Upon any such transfer, a new Warrant representing an equal aggregate number
of Warrants shall be issued and the old Warrant shall be cancelled by the Warrant Agent. In the case of certificated Warrants, the Warrants
so cancelled shall be delivered by the Warrant Agent to the Company from time to time upon request.

 

5.2            Procedure
for Surrender of Warrants. Warrants may be surrendered to the Warrant Agent, together with a written request for exchange or
transfer, and thereupon the Warrant Agent shall issue in exchange therefor one or more new Warrants as requested by the Registered
Holder of the Warrants so surrendered, representing an equal aggregate number of Warrants; provided, however, that
except as otherwise provided herein or in any Book-Entry Warrant Certificate or Definitive Warrant Certificate, each Book-Entry
Warrant Certificate and Definitive Warrant Certificate may be transferred only in whole and only to the Depositary, to another
nominee of the Depositary, to a successor depository, or to a nominee of a successor depository; provided further, however,
that in the event that a Warrant surrendered for transfer bears a restrictive legend (as in the case of the Private Placement
Warrants and the Working Capital Warrants), the Warrant Agent shall not cancel such Warrant and issue new Warrants in exchange
thereof until the Warrant Agent has received an opinion of counsel for the Company stating that such transfer may be made and
indicating whether the new Warrants must also bear a restrictive legend.

 

5.3            Fractional
Warrants. The Warrant Agent shall not be required to effect any registration of transfer or exchange which shall result in the issuance
of a warrant certificate or book-entry position for a fraction of a warrant.

 

5.4           Service Charges. No service charge shall be made for any exchange or registration of transfer of Warrants.

 

5.5            Warrant
Execution and Countersignature. The Warrant Agent is hereby authorized to countersign and to deliver, in accordance with the terms
of this Agreement, the Warrants required to be issued pursuant to the provisions of this Section 5, and the Company, whenever
required by the Warrant Agent, shall supply the Warrant Agent with Warrants duly executed on behalf of the Company for such purpose.

 

5.6            Transfer
of Warrants. Prior to the Detachment Date, the Public Warrants may be transferred or exchanged only together with the Unit in which
such Warrant is included, and only for the purpose of effecting, or in conjunction with, a transfer or exchange of such Unit. Furthermore,
each transfer of a Unit on the register relating to such Units shall operate also to transfer the Warrants included in such Unit. Notwithstanding
the foregoing, the provisions of this Section 5.6 shall have no effect on any transfer of Warrants on and after the Detachment
Date.

 

    12

     

    

 

6.             
Redemption.

 

6.1            Redemption.
Subject to Section 6.4 hereof, not less than all of the outstanding Warrants may be redeemed, at the option of the
Company, at any time while they are exercisable and prior to their expiration, at the office of the Warrant Agent, upon notice to
the Registered Holders of the Warrants, as described in Section 6.2 below, at the price of $0.01 per Warrant (the “Redemption
Price”), provided that the last sales price of the Common Stock reported has been at least $18.00 per share (the
 “Redemption Trigger Price”; subject to adjustment in compliance with Section 4 hereof), on
each of twenty (20) trading days within the thirty (30) trading-day period ending on the third trading day prior to the date on
which notice of the redemption is given and provided that there is an effective registration statement covering the shares of Common
Stock issuable upon exercise of the Warrants, and a current prospectus relating thereto, available throughout the 30-day Redemption
Period (as defined in Section 6.2 below) unless the Company has elected to require the exercise of the Warrants on a
 “cashless basis” pursuant to subsection 3.3.1; provided, however, that if and when the Public Warrants become
redeemable by the Company, the Company may not exercise such redemption right if the issuance of shares of Common Stock upon
exercise of the Public Warrants is not exempt from registration or qualification under applicable state blue sky laws or the Company
is unable to effect such registration or qualification.

 

6.2            Date
Fixed for, and Notice of, Redemption. In the event that the Company elects to redeem all of the Warrants, the Company shall fix
a date for the redemption (the “Redemption Date”). Notice of redemption shall be mailed by first class
mail, postage prepaid, by the Company not less than thirty (30) days prior to the Redemption Date (the “30-day
Redemption Period”) to the Registered Holders of the Warrants to be redeemed at their last addresses as they shall
appear on the registration books. Any notice mailed in the manner herein provided shall be conclusively presumed to have been duly
given whether or not the Registered Holder received such notice.

 

6.3            Exercise
After Notice of Redemption. The Warrants may be exercised, for cash (or on a “cashless basis” in accordance with subsection
3.3.1(b) of this Agreement) at any time after notice of redemption shall have been given by the Company pursuant to Section 6.2 hereof
and prior to the Redemption Date. In the event that the Company determines to require all holders of Warrants to exercise their
Warrants on a “cashless basis” pursuant to subsection 3.3.1, the notice of redemption shall contain the
information necessary to calculate the number of shares of Common Stock to be received upon exercise of the Warrants, including the
 “Fair Market Value” (as such term is defined in subsection 3.3.1(b) hereof) in such case. On and after the
Redemption Date, the record holder of the Warrants shall have no further rights except to receive, upon surrender of the Warrants,
the Redemption Price.

 

6.4            Exclusion
of Private Placement Warrants and Working Capital Warrants. The Company agrees that the redemption rights provided in this Section 6 shall
not apply to the Private Placement Warrants or the Working Capital Warrants if at the time of the redemption such Private Placement
Warrants or the Working Capital Warrants continue to be held by the Sponsor, Cantor and/or its designees or any Permitted
Transferees, as applicable. However, once such Private Placement Warrants or Working Capital Warrants are transferred (other than to
Permitted Transferees under Section 2.6), the Company may redeem the Private Placement Warrants and the Working Capital
Warrants, provided that the criteria for redemption are met, including the opportunity of the holder of such Private Placement
Warrants or the Working Capital Warrants to exercise the Private Placement Warrants and the Working Capital Warrants prior to
redemption pursuant to Section 6.3. Private Placement Warrants and Working Capital Warrants that are transferred to
persons other than Permitted Transferees shall upon such transfer cease to be Private Placement Warrants or Working Capital Warrants
and shall become Public Warrants under this Agreement.

 

7.              Other Provisions Relating to Rights of Holders of Warrants.

 

7.1            No
Rights as Stockholder. A Warrant does not entitle the Registered Holder thereof to any of the rights of a stockholder of the Company,
including, without limitation, the right to receive dividends, or other distributions, exercise any preemptive rights to vote or to consent
or to receive notice as stockholders in respect of the meetings of stockholders or the election of directors of the Company or any other
matter.

 

    13

     

    

 

7.2            Lost,
Stolen, Mutilated, or Destroyed Warrants. If any Warrant is lost, stolen, mutilated, or destroyed, the Company and the Warrant Agent
may on such terms as to indemnity or otherwise as they may in their discretion impose (which shall, in the case of a mutilated Warrant,
include the surrender thereof), issue a new Warrant of like denomination, tenor, and date as the Warrant so lost, stolen, mutilated, or
destroyed. Any such new Warrant shall constitute a substitute contractual obligation of the Company, whether or not the allegedly lost,
stolen, mutilated, or destroyed Warrant shall be at any time enforceable by anyone.

 

7.3            Reservation
of Common Stock. The Company shall at all times reserve and keep available a number of its authorized but unissued shares of Common
Stock that shall be sufficient to permit the exercise in full of all outstanding Warrants issued pursuant to this Agreement.

 

7.4           Registration of Common Stock; Cashless Exercise at Company’s Option.

 

7.4.1            Registration
of the Common Stock. The Company agrees that as soon as practicable, but in no event later than fifteen (15) Business Days after the
closing of its initial Business Combination, it shall use its best efforts to file with the Commission a registration statement for the
registration, under the Securities Act, of the shares of Common Stock issuable upon exercise of the Warrants. The Company shall use its
best efforts to cause the same to become effective and to maintain the effectiveness of such registration statement, and a current prospectus
relating thereto, until the expiration of the Warrants in accordance with the provisions of this Agreement. If any such registration statement
has not been declared effective by the 60th Business Day following the closing of the Business Combination, holders of the Warrants shall
have the right, during the period beginning on the 61st Business Day after the closing of the Business Combination and ending upon such
registration statement being declared effective by the Commission, and during any other period when the Company shall fail to have maintained
an effective registration statement covering the shares of Common Stock issuable upon exercise of the Warrants, to exercise such Warrants
on a “cashless basis,” by exchanging the Warrants (in accordance with Section 3(a)(9) of the Securities Act (or
any successor rule) or another exemption) for that number of shares of Common Stock equal to the quotient obtained by dividing (x) the
product of the number of shares of Common Stock underlying the Warrants, multiplied by the difference between the Warrant Price and the
 “Fair Market Value” (as defined below) by (y) the Fair Market Value. Solely for purposes of this subsection 7.4.1,
 “Fair Market Value” shall mean the volume weighted average price of the Common Stock as reported during the ten (10) trading
day period ending on the trading day prior to the date that notice of exercise is received by the Warrant Agent from the holder of such
Warrants or its securities broker or intermediary. The date that notice of cashless exercise is received by the Warrant Agent shall be
conclusively determined by the Warrant Agent. In connection with the “cashless exercise” of a Public Warrant, the Company
shall, upon request, provide the Warrant Agent with an opinion of counsel for the Company (which shall be an outside law firm with securities
law experience) stating that (i) the exercise of the Warrants on a cashless basis in accordance with this subsection 7.4.1
is not required to be registered under the Securities Act and (ii) the shares of Common Stock issued upon such exercise shall be
freely tradable under United States federal securities laws by anyone who is not an affiliate (as such term is defined in Rule 144
under the Securities Act (or any successor statute)) of the Company and, accordingly, shall not be required to bear a restrictive legend.
Except as provided in subsection 7.4.2, for the avoidance of any doubt, unless and until all of the Warrants have been exercised
or have expired, the Company shall continue to be obligated to comply with its registration obligations under the first three sentences
of this subsection 7.4.1.

 

    14

     

    

 

7.4.2            Cashless
Exercise at Company’s Option. If the Common Stock is at the time of any exercise of a Warrant not listed on a national
securities exchange such that it satisfies the definition of a “covered security” under Section 18(b)(1) of
the Securities Act (or any successor statute), the Company may, at its option, (i) require holders of Public Warrants who
exercise Public Warrants to exercise such Public Warrants on a “cashless basis” in accordance with
Section 3(a)(9) of the Securities Act (or any successor statute) as described in subsection 7.4.1 and (ii) in
the event the Company so elects, the Company shall not be required to file or maintain in effect a registration statement for the
registration, under the Securities Act, of the Common Stock issuable upon exercise of the Warrants, notwithstanding anything in this
Agreement to the contrary. If the Company does not elect at the time of exercise to require a holder of Public Warrants who
exercises Public Warrants to exercise such Public Warrants on a “cashless basis,” it agrees to use its best efforts to
register or qualify for sale the Common Stock issuable upon exercise of the Public Warrant under the blue sky laws of the state of
residence of the exercising Public Warrant holder to the extent an exemption is not available.

 

8.              Concerning the Warrant Agent and Other Matters.

 

8.1            Payment
of Taxes. The Company shall from time to time promptly pay all taxes and charges that may be imposed upon the Company or the Warrant
Agent in respect of the issuance or delivery of shares of Common Stock upon the exercise of the Warrants, but the Company shall not be
obligated to pay any transfer taxes in respect of the Warrants or such shares of Common Stock.

 

8.2           Resignation, Consolidation, or Merger of Warrant Agent.

 

8.2.1            Appointment
of Successor Warrant Agent. The Warrant Agent, or any successor to it hereafter appointed, may resign its duties and be discharged
from all further duties and liabilities hereunder after giving sixty (60) days’ notice in writing to the Company. If the office
of the Warrant Agent becomes vacant by resignation or incapacity to act or otherwise, the Company shall appoint in writing a successor
Warrant Agent in place of the Warrant Agent. If the Company shall fail to make such appointment within a period of thirty (30) days after
it has been notified in writing of such resignation or incapacity by the Warrant Agent or by the holder of a Warrant (who shall, with
such notice, submit his Warrant for inspection by the Company), then the holder of any Warrant may apply to the Supreme Court of the State
of New York for the County of New York for the appointment of a successor Warrant Agent at the Company’s cost. Any successor Warrant
Agent, whether appointed by the Company or by such court, shall be a corporation organized and existing under the laws of the State of
New York, in good standing and having its principal office in the Borough of Manhattan, City and State of New York, and authorized under
such laws to exercise corporate trust powers and subject to supervision or examination by federal or state authority. After appointment,
any successor Warrant Agent shall be vested with all the authority, powers, rights, immunities, duties, and obligations of its predecessor
Warrant Agent with like effect as if originally named as Warrant Agent hereunder, without any further act or deed; but if for any reason
it becomes necessary or appropriate, the predecessor Warrant Agent shall execute and deliver, at the expense of the Company, an instrument
transferring to such successor Warrant Agent all the authority, powers, and rights of such predecessor Warrant Agent hereunder; and upon
request of any successor Warrant Agent the Company shall make, execute, acknowledge, and deliver any and all instruments in writing for
more fully and effectually vesting in and confirming to such successor Warrant Agent all such authority, powers, rights, immunities, duties,
and obligations.

 

8.2.2            Notice
of Successor Warrant Agent. In the event a successor Warrant Agent shall be appointed, the Company shall give notice thereof to the
predecessor Warrant Agent and the Transfer Agent for the Common Stock not later than the effective date of any such appointment.

 

8.2.3            Merger
or Consolidation of Warrant Agent. Any corporation into which the Warrant Agent may be merged or with which it may be consolidated
or any corporation resulting from any merger or consolidation to which the Warrant Agent shall be a party shall be the successor Warrant
Agent under this Agreement without any further act.

 

8.3           Fees and Expenses of Warrant Agent.

 

8.3.1            Remuneration.
The Company agrees to pay the Warrant Agent reasonable remuneration for its services as such Warrant Agent hereunder and shall, pursuant
to its obligations under this Agreement, reimburse the Warrant Agent upon demand for all expenditures that the Warrant Agent may reasonably
incur in the execution of its duties hereunder.

 

    15

     

    

 

8.3.2            Further
Assurances. The Company agrees to perform, execute, acknowledge, and deliver or cause to be performed, executed, acknowledged, and
delivered all such further and other acts, instruments, and assurances as may reasonably be required by the Warrant Agent for the carrying
out or performing of the provisions of this Agreement.

 

8.4            Liability of Warrant Agent.

 

8.4.1            Reliance
on Company Statement. Whenever in the performance of its duties under this Agreement, the Warrant Agent shall deem it necessary or
desirable that any fact or matter be proved or established by the Company prior to taking or suffering any action hereunder, such fact
or matter (unless other evidence in respect thereof be herein specifically prescribed) may be deemed to be conclusively proved and established
by a statement signed by the Chief Executive Officer, Chief Financial Officer, President, Executive Vice President, Vice President, Secretary
or Chairman of the Board of the Company and delivered to the Warrant Agent. The Warrant Agent may rely upon such statement for any action
taken or suffered in good faith by it pursuant to the provisions of this Agreement.

 

8.4.2            Indemnity.
The Warrant Agent shall be liable hereunder only for its own gross negligence, willful misconduct or bad faith. The Company agrees to
indemnify the Warrant Agent and save it harmless against any and all liabilities, including judgments, costs and reasonable counsel fees,
for anything done or omitted by the Warrant Agent in the execution of this Agreement, except as a result of the Warrant Agent’s
gross negligence, willful misconduct or bad faith.

 

8.4.3            Exclusions.
The Warrant Agent shall have no responsibility with respect to the validity of this Agreement or with respect to the validity or execution
of any Warrant (except its countersignature thereof). The Warrant Agent shall not be responsible for any breach by the Company of any
covenant or condition contained in this Agreement or in any Warrant. The Warrant Agent shall not be responsible to make any adjustments
required under the provisions of Section 4 hereof or responsible for the manner, method, or amount of any such adjustment
or the ascertaining of the existence of facts that would require any such adjustment; nor shall it by any act hereunder be deemed to make
any representation or warranty as to the authorization or reservation of any shares of Common Stock to be issued pursuant to this Agreement
or any Warrant or as to whether any shares of Common Stock shall, when issued, be valid and fully paid and non-assessable.

 

8.5            Acceptance
of Agency. The Warrant Agent hereby accepts the agency established by this Agreement and agrees to perform the same upon the terms
and conditions herein set forth and among other things, shall account promptly to the Company with respect to Warrants exercised and concurrently
account for, and pay to the Company, all monies received by the Warrant Agent for the purchase of shares of Common Stock through the exercise
of the Warrants.

 

8.6            Waiver.
The Warrant Agent has no right of set-off or any other right, title, interest or claim of any kind (“Claim”)
in, or to any distribution of, the Trust Account (as defined in that certain Investment Management Trust Agreement, dated as of the date
hereof, by and between the Company and the Warrant Agent as trustee thereunder) and hereby agrees not to seek recourse, reimbursement,
payment or satisfaction for any Claim against the Trust Account for any reason whatsoever. The Warrant Agent hereby waives any and all
Claims against the Trust Account and any and all rights to seek access to the Trust Account.

 

    16

     

    

 

9.            
Miscellaneous Provisions.

 

9.1            Successors.
All the covenants and provisions of this Agreement by or for the benefit of the Company or the Warrant Agent shall bind and inure to the
benefit of their respective successors and assigns.

 

9.2            Notices.
Any notice, statement or demand authorized by this Agreement to be given or made by the Warrant Agent or by the holder of any Warrant
to or on the Company shall be sufficiently given when so delivered if by hand or overnight delivery or if sent by certified mail or private
courier service within five (5) days after deposit of such notice, postage prepaid, addressed (until another address is filed in
writing by the Company with the Warrant Agent), as follows:

 

Apeiron Capital Investment Corp. 

175 Federal Street, Suite 875 

Boston, Massachusetts 02110 

Attention: Dr. Joel Shulman

 

Any notice, statement or demand authorized by this Agreement to be
given or made by the holder of any Warrant or by the Company to or on the Warrant Agent shall be sufficiently given when so delivered
if by hand or overnight delivery or if sent by certified mail or private courier service within five (5) days after deposit of such
notice, postage prepaid, addressed (until another address is filed in writing by the Warrant Agent with the Company), as follows:

 

Continental Stock Transfer & Trust Company

 

1 State Street, 30th Floor

 

New York, NY 10004

 

Attention: Compliance Department

 

9.3            Applicable
Law and Exclusive Forum. The validity, interpretation, and performance of this Agreement and of the Warrants shall be governed in
all respects by the laws of the State of New York, without giving effect to conflicts of law principles that would result in the application
of the substantive laws of another jurisdiction. The Company hereby agrees that any action, proceeding or claim against it arising out
of or relating in any way to this Agreement shall be brought and enforced in the courts of the State of New York or the United States
District Court for the Southern District of New York, and irrevocably submits to such jurisdiction, which jurisdiction shall be the exclusive
forum for any such action, proceeding or claim. The Company hereby waives any objection to such exclusive jurisdiction and that such courts
represent an inconvenient forum. Notwithstanding the foregoing, the provisions of this paragraph will not apply to suits brought to enforce
any liability or duty created by the Exchange Act or any other claim for which the federal district courts of the United States of America
are the sole and exclusive forum.

 

Any person or entity purchasing or otherwise acquiring
any interest in the Warrants shall be deemed to have notice of and to have consented to the forum provisions in this Section 9.3.
If any action, the subject matter of which is within the scope the forum provisions above, is filed in a court other than a court located
within the State of New York or the United States District Court for the Southern District of New York (a “foreign action”)
in the name of any warrant holder, such warrant holder shall be deemed to have consented to: (x) the personal jurisdiction of the
state and federal courts located within the State of New York or the United States District Court for the Southern District of New York
in connection with any action brought in any such court to enforce the forum provisions (an “enforcement action”), and (y) having
service of process made upon such warrant holder in any such enforcement action by service upon such warrant holder’s counsel in
the foreign action as agent for such warrant holder.

 

9.4            Persons
Having Rights under this Agreement. Nothing in this Agreement shall be construed to confer upon, or give to, any person or
corporation other than the parties hereto and the Registered Holders of the Warrants and, for purposes of Sections 7.4, 9.4 and 9.8,
the Representative, any right, remedy, or claim under or by reason of this Agreement or of any covenant, condition, stipulation,
promise, or agreement hereof. All covenants, conditions, stipulations, promises, and agreements contained in this Agreement shall be
for the sole and exclusive benefit of the parties hereto and, for purposes of Sections 7.4, 9.4 and 9.8, the Representative, and
their successors and assigns and of the Registered Holders of the Warrants.

 

9.5            Examination
of the Warrant Agreement. A copy of this Agreement shall be available at all reasonable times at the office of the Warrant Agent in
the Borough of Manhattan, City and State of New York, for inspection by the Registered Holder of any Warrant. The Warrant Agent may require
any such holder to submit such holder’s Warrant for inspection by the Warrant Agent.

 

    17

     

    

 

9.6            Counterparts.
This Agreement may be executed in any number of original or facsimile counterparts and each of such counterparts shall for all purposes
be deemed to be an original, and all such counterparts shall together constitute but one and the same instrument.

 

9.7            Effect
of Headings. The section headings herein are for convenience only and are not part of this Agreement and shall not affect the interpretation
thereof.

 

9.8            Amendments.
This Agreement may be amended by the parties hereto without the consent of any Registered Holder (i)(A) for the purpose of curing
any ambiguity, or correcting any mistake including to conform the provisions of this Agreement to the description of the terms of the
Warrants and this Agreement in the Registration Statement or curing, correcting or supplementing any defective provision contained herein
or (B) for the purpose of adding or changing any other provisions with respect to matters or questions arising under this Agreement
as the parties may deem necessary or desirable and that the parties deem shall not adversely affect the interest of the Registered Holders,
and (ii) to provide for the delivery of Alternative Issuance pursuant to Section 4.4. All other modifications or amendments,
including any amendment to increase the Warrant Price or shorten the Exercise Period, shall require the vote or written consent of the
Registered Holders of a majority of the then outstanding Public Warrants. Any amendment solely to the Private Placement Warrants or the
Working Capital Warrants shall require the vote or written consent of a majority of the holders of the then outstanding Private Placement
Warrants or the Working Capital Warrants, as applicable. Notwithstanding the foregoing, the Company may lower the Warrant Price or extend
the duration of the Exercise Period pursuant to Sections 3.1 and 3.2, respectively, without the consent of the Registered
Holders.

 

9.9            Severability.
This Agreement shall be deemed severable, and the invalidity or unenforceability of any term or provision hereof shall not affect the
validity or enforceability of this Agreement or of any other term or provision hereof. Furthermore, in lieu of any such invalid or unenforceable
term or provision, the parties hereto intend that there shall be added as a part of this Agreement a provision as similar in terms to
such invalid or unenforceable provision as may be possible and be valid and enforceable.

 

[Signature Page Follows]

 

    18

     

    

  

IN WITNESS WHEREOF, the parties hereto have caused this Agreement
to be duly executed as of the date first above written.

 

	 	APEIRON CAPITAL INVESTMENT CORP.
	 	 
	 	By:	 /s/ Joel Shulman 
	 	Name: 	 Dr. Joel Shulman
	 	Title:	 Chief Executive Officer
	 	 	 
	 	CONTINENTAL STOCK TRANSFER & TRUST COMPANY, as Warrant Agent
	 	 	 
	 	By:	 /s/ Douglas Reed 
	 	Name:	 Douglas Reed
	 	Title:	 Vice President

 

[Signature Page to Warrant Agreement]

 

    19

     

    

 

 

EXHIBIT A

 

[Form of Warrant Certificate]

 

[FACE]

 

Number

 

Warrants

 

THIS WARRANT SHALL BE VOID IF NOT EXERCISED
PRIOR TO THE EXPIRATION OF THE EXERCISE PERIOD PROVIDED FOR IN THE WARRANT AGREEMENT DESCRIBED BELOW

 

APEIRON CAPITAL INVESTMENT CORP.

Incorporated Under the Laws of the State of
Delaware

 

CUSIP 03752A 119

 

Warrant Certificate

 

This
Warrant Certificate certifies that     , or registered assigns, is the registered holder of
          warrant(s) evidenced hereby (the “Warrants” and each, a “Warrant”) to purchase shares of Class A
common stock, $0.0001 par value per share (“Common Stock”), of Apeiron Capital Investment Corp., a Delaware
corporation (the “Company”). Each Warrant entitles the holder, upon exercise during the period set forth in
the Warrant Agreement referred to below, to receive from the Company that number of fully paid and non-assessable shares of Common Stock
as set forth below, at the exercise price (the “Exercise Price”) as determined pursuant to the Warrant Agreement,
payable in US dollars, by bank wire or certified check (or through “cashless exercise” as provided for in the
Warrant Agreement) of the United States of America upon surrender of this Warrant Certificate and payment of the Exercise Price at the
office or agency of the Warrant Agent referred to below, subject to the conditions set forth herein and in the Warrant Agreement. Defined
terms used in this Warrant Certificate but not defined herein shall have the meanings given to them in the Warrant Agreement.

 

Each whole Warrant is initially exercisable
for one fully paid and non-assessable share of Common Stock. No fractional shares will be issued upon exercise of any Warrant. If,
upon the exercise of Warrants, a holder would be entitled to receive a fractional interest in a share of Common Stock, the Company
will, upon exercise, round down to the nearest whole number the number of shares of Common Stock to be issued to the Warrant holder.
The number of shares of Common Stock issuable upon exercise of the Warrants is subject to adjustment upon the occurrence of certain
events set forth in the Warrant Agreement.

 

    20

     

    

 

The initial Exercise Price per share of Common
Stock for any Warrant is equal to $11.50 per whole share. The Exercise Price is subject to adjustment upon the occurrence of certain events
set forth in the Warrant Agreement.

 

Subject to the conditions set forth in the Warrant
Agreement, the Warrants may be exercised only during the Exercise Period and to the extent not exercised by the end of such Exercise Period,
such Warrants shall become void.

 

Reference is hereby made to the further provisions
of this Warrant Certificate set forth on the reverse hereof and such further provisions shall for all purposes have the same effect as
though fully set forth at this place.

 

This Warrant Certificate shall not be valid unless
countersigned by the Warrant Agent, as such term is used in the Warrant Agreement.

 

This Warrant Certificate shall be governed by
and construed in accordance with the internal laws of the State of New York, without regard to conflicts of laws principles thereof.

 

	 	APEIRON CAPITAL INVESTMENT CORP.
	 	 
	 	By:	            
	 	Name:
	 	Title:
	 	 
	 	CONTINENTAL STOCK TRANSFER & TRUST COMPANY, as Warrant Agent

 

	 	By:	 
	 	Name:
	 	Title:

 

    21

     

    

 

[Form of Warrant Certificate]

 

[Reverse]

 

The Warrants evidenced by this Warrant Certificate
are part of a duly authorized issue of Warrants entitling the holder on exercise to receive shares of Common Stock and are issued or to
be issued pursuant to a Warrant Agreement dated as of     , 2021 (the “Warrant Agreement”),
duly executed and delivered by the Company to Continental Stock Transfer & Trust Company, a New York corporation, as warrant
agent (the “Warrant Agent”), which Warrant Agreement is hereby incorporated by reference in and made a part
of this instrument and is hereby referred to for a description of the rights, limitation of rights, obligations, duties and immunities
thereunder of the Warrant Agent, the Company and the holders (the words “holders” or “holder”
meaning the Registered Holders or Registered Holder, respectively) of the Warrants. A copy of the Warrant Agreement may be obtained by
the holder hereof upon written request to the Company. Defined terms used in this Warrant Certificate but not defined herein shall have
the meanings given to them in the Warrant Agreement.

 

Warrants may be exercised at any time during the Exercise Period
set forth in the Warrant Agreement. The holder of Warrants evidenced by this Warrant Certificate may exercise them by surrendering this
Warrant Certificate, with the form of election to purchase set forth hereon properly completed and executed, together with payment of
the Exercise Price as specified in the Warrant Agreement (or through “cashless exercise” as provided for in the Warrant Agreement)
at the principal corporate trust office of the Warrant Agent. In the event that upon any exercise of Warrants evidenced hereby the number
of Warrants exercised shall be less than the total number of Warrants evidenced hereby, there shall be issued to the holder hereof or
his, her or its assignee, a new Warrant Certificate evidencing the number of Warrants not exercised.

 

Notwithstanding anything else in this Warrant
Certificate or the Warrant Agreement, no Warrant may be exercised unless at the time of exercise (i) a registration statement covering
the shares of Common Stock to be issued upon exercise is effective under the Securities Act and (ii) a prospectus thereunder relating
to the shares of Common Stock is current, except through “cashless exercise” as provided for in the Warrant Agreement.

 

The Warrant Agreement provides that upon the occurrence
of certain events the number of shares of Common Stock issuable upon exercise of the Warrants set forth on the face hereof may, subject
to certain conditions, be adjusted. If, upon exercise of a Warrant, the holder thereof would be entitled to receive a fractional interest
in a share of Common Stock, the Company shall, upon exercise, round down to the nearest whole number of shares of Common Stock to be issued
to the holder of the Warrant.

 

Warrant Certificates, when surrendered at the
principal corporate trust office of the Warrant Agent by the Registered Holder thereof in person or by legal representative or attorney
duly authorized in writing, may be exchanged, in the manner and subject to the limitations provided in the Warrant Agreement, but without
payment of any service charge, for another Warrant Certificate or Warrant Certificates of like tenor evidencing in the aggregate a like
number of Warrants.

 

Upon due presentation for registration of transfer
of this Warrant Certificate at the office of the Warrant Agent a new Warrant Certificate or Warrant Certificates of like tenor and evidencing
in the aggregate a like number of Warrants shall be issued to the transferee(s) in exchange for this Warrant Certificate, subject
to the limitations provided in the Warrant Agreement, without charge except for any tax or other governmental charge imposed in connection
therewith.

 

The Company and the Warrant Agent may deem and
treat the Registered Holder(s) hereof as the absolute owner(s) of this Warrant Certificate (notwithstanding any notation of
ownership or other writing hereon made by anyone), for the purpose of any exercise hereof, of any distribution to the holder(s) hereof,
and for all other purposes, and neither the Company nor the Warrant Agent shall be affected by any notice to the contrary. Neither the
Warrants nor this Warrant Certificate entitles any holder hereof to any rights of a stockholder of the Company.

 

    22

     

    

 

Election to Purchase

 

(To Be Executed Upon Exercise of Warrant)

 

The undersigned hereby irrevocably elects to
exercise the right, represented by this Warrant Certificate, to receive     shares of Common Stock and
herewith tenders payment for such shares of Common Stock to the order of Apeiron Capital Investment Corp. (the “Company”)
in the amount of $         in accordance with the terms hereof. The undersigned
requests that a certificate for such shares of Common Stock be registered in the name of     , whose
address is     and that such shares of Common Stock be delivered
to     whose address is     . If said number of shares of Common Stock is
less than all of the shares of Common Stock purchasable hereunder, the undersigned requests that a new Warrant Certificate
representing the remaining balance of such shares of Common Stock be registered in the name
of          , whose address
is          and that such Warrant Certificate be delivered
to     , whose address is     .

 

In the event that the Warrant has been called
for redemption by the Company pursuant to Section 6 of the Warrant Agreement and the Company has required cashless exercise
pursuant to Section 6.3 of the Warrant Agreement, the number of shares of Common Stock that this Warrant is exercisable for
shall be determined in accordance with subsection 3.3.1(b) and Section 6.3 of the Warrant Agreement.

 

In the event that the Warrant is a Private Placement
Warrant,a Working Capital Warrant or Post-IPO Warrant that is to be exercised on a “cashless” basis pursuant to subsection
3.3.1(c) of the Warrant Agreement, the number of shares of Common Stock that this Warrant is exercisable for shall be determined
in accordance with subsection 3.3.1(c) of the Warrant Agreement.

 

In the event that the Warrant is to be exercised
on a “cashless” basis pursuant to Section 7.4 of the Warrant Agreement, the number of shares of Common Stock that
this Warrant is exercisable for shall be determined in accordance with Section 7.4 of the Warrant Agreement.

 

In the event that the Warrant may be exercised,
to the extent allowed by the Warrant Agreement, through cashless exercise (i) the number of shares of Common Stock that this Warrant
is exercisable for would be determined in accordance with the relevant section of the Warrant Agreement which allows for such cashless
exercise and (ii) the holder hereof shall complete the following: The undersigned hereby irrevocably elects to exercise the right,
represented by this Warrant Certificate, through the cashless exercise provisions of the Warrant Agreement, to receive shares of Common
Stock. If said number of shares of Common Stock is less than all of the shares of Common Stock purchasable hereunder (after giving effect
to the cashless exercise), the undersigned requests that a new Warrant Certificate representing the remaining balance of such shares of
Common Stock be registered in the name of     , whose address is        and
that such Warrant Certificate be delivered to     , whose address is     .

 

[Signature Page Follows]

 

    23

     

    

 

	Date:     , 2021	 
	 	(Signature)
	 	 
	 	 
	 	 
	 	 
	 	(Address)
	 	 
	 	 
	 	(Tax Identification Number)
	 	 
	Signature Guaranteed:	 
	 	 
	 	 

 

THE SIGNATURE(S) SHOULD BE GUARANTEED BY
AN ELIGIBLE GUARANTOR INSTITUTION (BANKS, STOCKBROKERS, SAVINGS AND LOAN ASSOCIATIONS AND CREDIT UNIONS WITH MEMBERSHIP IN AN APPROVED
SIGNATURE GUARANTEE MEDALLION PROGRAM, PURSUANT TO S.E.C. RULE 17Ad-15 (OR ANY SUCCESSOR RULE)).

 

    24

     

    

 

EXHIBIT B LEGEND

 

“THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN
REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS, AND MAY NOT BE OFFERED, SOLD, TRANSFERRED
OR OTHERWISE DISPOSED OF UNLESS REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND ANY APPLICABLE STATE SECURITIES LAWS OR AN
EXEMPTION FROM REGISTRATION IS AVAILABLE. IN ADDITION, SUBJECT TO ANY ADDITIONAL LIMITATIONS ON TRANSFER DESCRIBED IN THE LETTER AGREEMENT
BY AND AMONG APEIRON CAPITAL INVESTMENT CORP. (THE “COMPANY”), APEIRON CAPITAL SPONSOR, LLC AND THE OTHER PARTIES THERETO,
THE SECURITIES REPRESENTED BY THIS CERTIFICATE MAY NOT BE SOLD OR TRANSFERRED PRIOR TO THE DATE THAT IS THIRTY (30) DAYS AFTER THE
DATE UPON WHICH THE COMPANY COMPLETES ITS INITIAL BUSINESS COMBINATION (AS DEFINED IN SECTION 3 OF THE WARRANT AGREEMENT REFERRED
TO HEREIN) EXCEPT TO A PERMITTED TRANSFEREE (AS DEFINED IN SECTION 2 OF THE WARRANT AGREEMENT) WHO AGREES IN WRITING WITH THE COMPANY
TO BE SUBJECT TO SUCH TRANSFER PROVISIONS.

 

SECURITIES EVIDENCED BY THIS CERTIFICATE AND SHARES OF CLASS A
COMMON STOCK OF THE COMPANY ISSUED UPON EXERCISE OF SUCH SECURITIES SHALL BE ENTITLED TO REGISTRATION RIGHTS UNDER A REGISTRATION RIGHTS
AGREEMENT TO BE EXECUTED BY THE COMPANY.”

 

EXHIBIT C

 

LEGEND

 

“THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN
REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS, AND MAY NOT BE OFFERED, SOLD, TRANSFERRED
OR OTHERWISE DISPOSED OF UNLESS REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND ANY APPLICABLE STATE SECURITIES LAWS OR AN
EXEMPTION FROM REGISTRATION IS AVAILABLE. IN ADDITION, SUBJECT TO ANY ADDITIONAL LIMITATIONS ON TRANSFER DESCRIBED IN THE LETTER AGREEMENT
BY AND AMONG APEIRON CAPITAL INVESTMENT CORP. (THE “COMPANY”) AND CANTOR FITZGERALD & CO., THE SECURITIES REPRESENTED
BY THIS CERTIFICATE MAY NOT BE SOLD OR TRANSFERRED PRIOR TO THE DATE THAT IS THIRTY (30) DAYS AFTER THE DATE UPON WHICH THE COMPANY
COMPLETES ITS INITIAL BUSINESS COMBINATION (AS DEFINED IN SECTION 3 OF THE WARRANT AGREEMENT REFERRED TO HEREIN) EXCEPT TO A PERMITTED
TRANSFEREE (AS DEFINED IN SECTION 2 OF THE WARRANT AGREEMENT) WHO AGREES IN WRITING WITH THE COMPANY TO BE SUBJECT TO SUCH TRANSFER
PROVISIONS.

 

SECURITIES EVIDENCED BY THIS CERTIFICATE AND SHARES OF CLASS A
COMMON STOCK OF THE COMPANY ISSUED UPON EXERCISE OF SUCH SECURITIES SHALL BE ENTITLED TO REGISTRATION RIGHTS UNDER A REGISTRATION RIGHTS
AGREEMENT TO BE EXECUTED BY THE COMPANY.”

 

    25

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00336-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00336-of-00352.parquet"}]]